Other disorders of nervous system

G6_NEUROOTH

nervous system disease: A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G98, G99*
  • Cause of death: ICD-10 G98, G99*

2 out of 7 registries used, show all original rules.

2489

4. Check minimum number of events

None

2489

5. Include endpoints

None

2489

6. Filter based on genotype QC (FinnGen only)

2489

Control definitions (FinnGen only)

Control exclude
G6_OTHNEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 13637 6281 7307
Only index persons 12774 5937 6837
Unadjusted period prevalence (%)
Whole population 0.19 0.18 0.20
Only index persons 0.24 0.22 0.26
Median age at first event (years)
Whole population 58.90 59.38 58.44
Only index persons 58.38 58.76 58.05

-FinnGen-

Key figures

All Female Male
Number of individuals 2489 1234 1255
Unadjusted period prevalence (%) 0.49 0.42 0.55
Median age at first event (years) 59.15 57.67 60.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2257
Matched controls
22570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
8596.1
323.0
637
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
19.0
323.0
654
474
M48.0
ICD-10 Finland
Spinal stenosis
11.4
323.0
1001
1479
G99.2*M51.0
ICD-10 Finland
Lumbar and other intervertebral disc disorders with myelopathy
1208.6
323.0
313
*
G99.2*M50.0
ICD-10 Finland
Cervical disc disorder with myelopathy
1698.0
323.0
523
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
27.8
323.0
473
213
G99.2
ICD-10 Finland
Myelopathy in diseases classified elsewhere
962.8
323.0
398
5
N03AX16
ATC
pregabalin; oral
6.2
323.0
1164
3288
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
23.3
323.0
531
294
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
187.7
323.0
376
24
G99.2*M47.9
ICD-10 Finland
Myelopathy in spondylosis
1163.9
317.4
303
*
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
53.7
315.0
377
84
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
14.6
293.1
523
457
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
10.0
251.4
549
706
N03AX12
ATC
gabapentin; oral
6.1
250.7
821
1931
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
5.5
205.9
726
1797
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
6.3
191.2
573
1148
N02AX02
ATC
tramadol; systemic, rectal
3.6
181.4
1391
6910
G99.2*M47.0
ICD-10 Finland
Anterior spinal and vertebral artery compression syndromes
+∞
160.3
152
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
159.8
996
4055
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.2
154.7
547
1303
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
7.4
153.9
397
631
M47.9
ICD-10 Finland
Spondylosis, unspecified
10.9
148.2
298
310
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
8.0
144.1
352
512
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.2
143.5
502
1171
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
16.9
142.0
233
153
NAG41
NOMESCO Finland
Anterior fusion of cervical spine with fixation
46.5
133.4
164
38
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
17.8
129.7
208
128
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
20.8
128.7
195
102
N06AX21
ATC
duloxetine; oral
4.5
111.4
450
1192
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
7.7
108.9
268
387
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
8.7
106.1
241
306
L01
ICPC
Neck symptom/complaint
3.9
106.0
511
1586
ABC50
NOMESCO Finland
Decopression of cervical spinal canal and nerve roots
77.9
98.2
111
15
M03BX01
ATC
baclofen; systemic
16.3
97.4
161
106
G98
ICD-10 Finland
Other disorders of nervous system, not elsewhere classified
913.8
90.4
88
*
M54.5
ICD-10 Finland
Low back pain
2.6
88.8
912
4679
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
21.2
88.0
132
66
AA1AD
NOMESCO Finland
CT of head and brain
2.9
87.3
664
2838
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
87.1
851
4230
M50.3
ICD-10 Finland
Other cervical disc degeneration
9.2
82.1
178
207
G99.0*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy
+∞
81.8
78
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
80.5
543
2127
N06AA09
ATC
amitriptyline; systemic
3.7
78.7
391
1217
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
13.2
78.5
141
113
M54.4
ICD-10 Finland
Lumbago with sciatica
3.0
77.8
534
2110
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
77.0
1213
7578
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.0
76.1
338
953
M03BX02
ATC
tizanidine; oral
2.3
75.9
1547
10900
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
20.1
75.6
115
60
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.2
75.0
448
1602
XKD06
NOMESCO Finland
Physiologic investigation of micturition
7.3
74.5
188
278
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
16.3
73.7
121
78
L28
ICPC
Limited function/disability (L)
3.0
71.5
475
1824
M54.1
ICD-10 Finland
Radiculopathy
6.4
71.3
198
334
M54.2
ICD-10 Finland
Cervicalgia
4.3
71.0
286
734
N02BE01
ATC
paracetamol; systemic, rectal
3.0
70.5
2023
16691
NA1AD
NOMESCO Finland
Cervical spine CT examination
6.0
68.5
201
364
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
67.9
1122
7004
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
67.6
969
5665
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.8
67.4
515
2152
M50.0
ICD-10 Finland
Cervical disc disorder with myelopathy
146.5
67.3
71
5
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
+∞
67.0
64
*
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
7.2
65.7
167
249
G99.0*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy
+∞
63.8
61
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
7.4
63.0
157
227
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
62.9
445
1765
L86
ICPC
Back syndrome with radiating pain
4.5
61.8
233
558
N02AA05
ATC
oxycodone; systemic
2.8
61.5
456
1861
XKC03
NOMESCO Finland
Water cystometry
6.1
61.0
174
303
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.6
60.1
185
354
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
59.8
270
764
L03
ICPC
Low back symptom/complaint
2.4
59.2
648
3276
M79.6
ICD-10 Finland
Pain in limb
2.1
57.5
891
5281
SPAT1262
SPAT
Handing over of treatment supplies
2.5
56.6
535
2498
A02BC02
ATC
pantoprazole; systemic
2.1
56.4
1547
11553
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
5.8
56.2
168
310
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.1
55.8
344
1237
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
55.7
268
799
M03BC01
ATC
orphenadrine (citrate); systemic
2.3
54.9
629
3230
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
8.0
54.4
127
166
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.8
53.8
141
219
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.1
53.2
328
1177
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
57.9
52.8
62
11
M01AH05
ATC
etoricoxib; oral
2.0
52.4
1417
10359
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
19.2
52.1
80
43
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
51.6
915
5665
N03AE01
ATC
clonazepam; systemic
4.1
51.2
214
563
WX110
NOMESCO Finland
Local anesthesy
2.0
51.2
1583
12134
SPAT1229
SPAT
Assessment of need for aid
3.5
51.1
265
837
ZXD05
NOMESCO Finland
Urgent procedure
2.1
49.8
763
4431
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
16.1
49.5
81
52
S18
ICPC
Laceration/cut
1.9
47.9
1034
6846
WX402
NOMESCO Finland
General anaesthesia
2.4
47.8
475
2250
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
47.6
411
1808
G992, M472
ICD-10 Finland
NA
+∞
47.0
45
*
UKC02
NOMESCO Finland
Cystoscopy
2.4
45.9
461
2193
G82.2
ICD-10 Finland
Paraplegia, unspecified
32.4
45.6
60
19
N03AX09
ATC
lamotrigine; oral
4.9
45.2
155
334
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
45.1
729
4288
G992, M480
ICD-10 Finland
NA
+∞
44.9
43
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
9.3
44.8
95
106
L83
ICPC
Neck syndrome
13.4
44.7
79
61
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.6
44.6
107
146
ABC63
NOMESCO Finland
Decompression of thoracic spinal cord
446.2
44.4
44
*
J01FF01
ATC
clindamycin; systemic
2.0
43.8
696
4060
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
12.0
43.6
81
70
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
5.7
43.6
130
239
M50.9
ICD-10 Finland
Cervical disc disorder, unspecified
15.5
43.4
72
48
SPAT1153
SPAT
Removal of sutures
2.0
43.2
808
5013
SPAT1263
SPAT
Sampling
1.9
43.1
976
6491
NAG42
NOMESCO Finland
Posterior fusion of cervical spine with or without fixation
39.5
42.9
54
14
M47.82
ICD-10 Finland
Other spondylosis, cervical region
4.4
42.7
163
392
M43.1
ICD-10 Finland
Spondylolisthesis
4.5
42.3
159
377
R20.2
ICD-10 Finland
Paraesthesia of skin
3.6
42.2
204
606
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
149.5
41.9
44
*
C03CA01
ATC
furosemide; systemic
2.0
41.8
667
3880
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
41.6
242
827
ABC10
NOMESCO Finland
Microsurgical excision of cervical intervertebral disc displacement
32.5
41.1
54
17
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
12.7
41.0
74
60
N06AX16
ATC
venlafaxine; oral
2.5
41.0
362
1601
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
40.6
197
587
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
40.3
700
4197
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.1
39.1
159
406
A02BC05
ATC
esomeprazole; systemic
1.8
38.6
951
6432
J01MA02
ATC
ciprofloxacin; systemic
1.8
38.1
916
6134
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
11.1
37.9
73
68
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
6.0
37.8
108
188
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
37.4
474
2487
R42
ICD-10 Finland
Dizziness and giddiness
2.1
37.2
492
2631
S97
ICPC
Chronic ulcer skin
3.6
37.0
175
510
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
36.8
538
2997
N06AA10
ATC
nortriptyline; systemic
6.5
36.6
98
157
G992M
ICD-10 Finland
NA
+∞
36.6
35
*
NF1AA
NOMESCO Finland
Hip X-ray examination
2.8
36.3
251
958
J01DB01
ATC
cefalexin; oral
1.9
36.2
1827
15468
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
36.2
930
6338
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
36.1
524
2905
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
36.0
287
1195
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.5
35.4
108
204
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
11.7
35.3
66
58
SPAT1216
SPAT
Assessment of functional ability
2.3
34.9
380
1856
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.4
34.8
133
320
N06AX11
ATC
mirtazapine; oral
1.9
34.8
726
4599
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
34.4
642
3905
M01AH02
ATC
rofecoxib; oral
2.3
34.2
358
1715
R1250
NOMESCO Finland
Evaluation of functional capability
5.8
34.0
99
177
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
33.9
213
764
H02AB06
ATC
prednisolone; systemic
1.7
33.9
1050
7536
R06.0
ICD-10 Finland
Dyspnoea
1.9
33.8
576
3385
J01MA12
ATC
levofloxacin; systemic
2.1
33.7
471
2563
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
5.3
33.7
106
208
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.3
33.6
131
322
N05CF01
ATC
zopiclone; oral
1.8
33.6
753
4873
N18
ICPC
Paralysis/weakness
7.4
33.4
81
113
A28
ICPC
Limited function/disability NOS
2.3
33.3
348
1664
A06AD11
ATC
lactulose; oral
2.3
33.2
351
1686
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.9
33.1
593
3549
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.0
33.0
110
230
M01AB05
ATC
diclofenac; systemic, rectal
1.7
33.0
1516
12192
M25.5
ICD-10 Finland
Pain in joint
1.9
33.0
647
3995
R52.2
ICD-10 Finland
Other chronic pain
4.4
32.9
124
295
R51.80
ICD-10 Finland
Headache
2.3
32.7
325
1515
G47.3
ICD-10 Finland
Sleep apnoea
2.0
32.6
536
3101
G992, M511
ICD-10 Finland
NA
+∞
32.4
31
*
A01
ICPC
Pain general/multiple sites
2.9
32.3
213
787
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
12.6
32.3
58
47
ABC53
NOMESCO Finland
Decompression of thoracic spinal canal and nerve roots
115.0
31.7
34
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
22.9
31.4
45
20
ACC51
NOMESCO Finland
Release of median nerve
2.8
31.3
215
815
R4120
NOMESCO Finland
Occupational therapy
3.0
31.3
191
672
R4110
NOMESCO Finland
Physiotherapy
1.8
31.3
640
3998
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
7.0
31.3
79
117
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
31.3
343
1675
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.9
31.1
590
3586
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
30.9
299
1374
XX2CT
NOMESCO Finland
Other injection with CT guidance
29.8
30.8
41
14
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
111.6
30.7
33
*
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
26.7
30.6
42
16
M54.3
ICD-10 Finland
Sciatica
3.1
30.3
179
615
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
6.0
30.2
85
146
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.8
30.1
210
805
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
30.0
653
4153
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
29.9
200
746
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
29.7
225
906
G56.2
ICD-10 Finland
Lesion of ulnar nerve
4.0
29.5
121
312
G44.2
ICD-10 Finland
Tension-type headache
2.3
29.4
303
1431
R33
ICD-10 Finland
Retention of urine
2.7
29.4
219
873
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.7
29.3
76
117
G54.0
ICD-10 Finland
Brachial plexus disorders
5.9
29.2
84
148
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.4
29.2
150
466
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
28.9
273
1236
Z50.1
ICD-10 Finland
Other physical therapy
3.0
28.9
175
611
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
28.8
278
1274
SPAT1301
SPAT
No procedures
1.8
28.5
702
4624
WX704
NOMESCO Finland
Intubation
2.7
28.4
206
807
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
28.3
507
3008
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
28.0
348
1790
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
27.9
187
696
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
27.8
156
515
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
27.7
1290
10143
N02AC04
ATC
dextropropoxyphene; oral
3.7
27.7
126
355
M51.0
ICD-10 Finland
Lumbar and other intervertebral disc disorders with myelopathy
35.5
27.4
35
10
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
27.4
744
5038
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.7
27.3
204
813
A02BC01
ATC
omeprazole; systemic
1.8
27.3
638
4126
M54
ICD-10 Finland
Dorsalgia
2.3
27.2
272
1266
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
24.1
27.0
38
16
A10AE04
ATC
insulin glargine; parenteral
2.4
26.9
248
1108
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
26.8
275
1295
R13
ICD-10 Finland
Dysphagia
2.9
26.8
177
653
A46
ICD-10 Finland
Erysipelas
2.1
26.8
347
1812
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
26.5
863
6136
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.9
26.5
167
599
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
6.9
26.5
67
100
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
26.3
532
3279
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
26.1
25
*
G99.0
ICD-10 Finland
Autonomic neuropathy in endocrine and metabolic diseases
+∞
26.1
25
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
25.9
317
1618
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
25.9
607
3918
M79.1
ICD-10 Finland
Myalgia
2.1
25.8
304
1525
J01DA01
ATC
[U] cefalexin; systemic
1.6
25.8
1351
10859
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.7
25.8
193
768
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
25.7
218
930
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
25.7
297
1476
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
25.6
481
2886
M48.9
ICD-10 Finland
Spondylopathy, unspecified
14.7
25.2
42
29
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.3
25.0
258
1216
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
25.0
538
3372
XKD00
NOMESCO Finland
Uroflowmetry
1.9
25.0
401
2273
M01AH01
ATC
celecoxib; oral (coxibs)
1.9
24.9
441
2592
NAG65
NOMESCO Finland
Anterior and posterior fusion of lumbar spine
17.2
24.9
39
23
R60.0
ICD-10 Finland
Localized oedema
2.2
24.9
264
1262
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
23.7
24.8
35
15
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
10.2
24.8
49
49
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.8
24.7
491
2996
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
24.7
363
1990
TKC20
NOMESCO Finland
Catheterisation of bladder
2.6
24.7
191
776
M54.6
ICD-10 Finland
Pain in thoracic spine
2.8
24.6
166
623
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.7
24.5
110
307
Z3226
NOMESCO Finland
Physiotherapist
1.9
24.4
433
2543
UJF32
NOMESCO Finland
Coloscopy
1.7
24.3
585
3791
N05BA01
ATC
diazepam; systemic, rectal
2.1
24.3
318
1665
L02
ICPC
Back symptom/complaint
2.4
24.2
215
941
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
9.8
23.8
48
50
N06AB04
ATC
citalopram; systemic
1.8
23.6
477
2921
L13
ICPC
Hip symptom/complaint
1.9
23.6
362
2015
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
6.6
23.6
61
94
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
126.3
23.6
25
*
G82.5
ICD-10 Finland
Tetraplegia, unspecified
126.3
23.6
25
*
T90
ICPC
Diabetes non-insulin dependent
1.8
23.6
527
3335
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
9.6
23.5
48
51
L08
ICPC
Shoulder symptom/complaint
1.8
23.5
447
2684
M01AX17
ATC
nimesulide; oral
1.7
23.4
570
3702
L12
ICPC
Hand/finger symptom/complaint
2.0
23.3
324
1737
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
3.6
23.2
108
311
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
23.2
295
1523
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
11.5
23.2
43
38
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
23.1
185
766
L17
ICPC
Foot/toe symptom/complaint
1.7
23.0
553
3571
A10AA01
ATC
NA
4.2
22.8
89
220
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.4
22.8
83
192
M01AE02
ATC
naproxen; oral, rectal
1.6
22.7
1212
9639
S14.0
ICD-10 Finland
Concussion and oedema of cervical spinal cord
40.5
22.7
28
7
G82.1
ICD-10 Finland
Spastic paraplegia
232.2
22.7
23
*
G55.2
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
10.9
22.6
43
40
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
22.4
1069
8268
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
22.2
284
1471
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
24.1
22.2
31
13
ZZH40
NOMESCO Finland
Substitute of bone
8.9
22.1
47
54
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.9
22.1
141
509
A10AA02
ATC
NA
3.6
22.0
103
299
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
21.8
254
1265
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
21.7
287
1504
SPAT1254
SPAT
Administration of medicine
2.0
21.7
318
1736
N04BC05
ATC
pramipexole; oral
2.5
21.7
182
772
N81
ICPC
Injury nervous system other
18.6
21.7
33
18
NAG52
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, 2-3 vertebraea
43.8
21.4
26
6
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
21.4
896
6692
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.1
21.3
119
394
R52.9
ICD-10 Finland
Pain, unspecified
2.3
21.3
201
905
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.9
21.3
70
146
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
21.2
306
1659
A02BC03
ATC
lansoprazole; oral
1.6
21.2
632
4325
N30.0
ICD-10 Finland
Acute cystitis
2.0
21.1
284
1499
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.4
21.1
105
320
M01AB55
ATC
diclofenac, combinations; oral
2.4
21.0
188
823
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.5
20.9
177
755
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.4
20.9
103
311
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
+∞
20.9
20
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
20.7
816
5988
TAB00
NOMESCO Finland
Lumbar puncture
3.1
20.6
114
375
C08CA01
ATC
amlodipine; oral
1.6
20.6
774
5618
N03AF01
ATC
carbamazepine; oral, rectal
2.9
20.6
133
485
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
30.3
20.6
27
9
N28
ICPC
Limited function/disability (N)
6.4
20.5
54
86
N05BA04
ATC
oxazepam; oral
1.7
20.5
515
3355
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
20.5
190
848
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
20.4
408
2482
R53
ICD-10 Finland
Malaise and fatigue
1.8
20.3
399
2413
M01AB51
ATC
indometacin, combinations; oral, rectal
3.9
20.3
85
225
A10AE05
ATC
insulin detemir; parenteral
2.7
20.2
147
576
R11
ICD-10 Finland
Nausea and vomiting
2.4
20.2
176
763
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
32.8
20.2
26
8
M70.6
ICD-10 Finland
Trochanteric bursitis
2.0
20.2
269
1411
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
20.2
681
4803
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.3
20.1
104
326
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.2
20.1
109
354
M41.9
ICD-10 Finland
Scoliosis, unspecified
6.9
20.0
50
74
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
20.0
392
2367
L14
ICPC
Leg/thigh symptom/complaint
2.4
20.0
179
786
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
21.0
19.9
29
14
ACC53
NOMESCO Finland
Release of ulnar nerve
5.2
19.9
62
122
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
19.9
204
957
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
6.8
19.9
50
75
R52.1
ICD-10 Finland
Chronic intractable pain
7.7
19.9
46
61
M01AC06
ATC
meloxicam; systemic, rectal
1.6
19.8
800
5890
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
19.8
310
1732
M43.0
ICD-10 Finland
Spondylolysis
4.7
19.8
68
149
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.3
19.7
188
850
ABC21
NOMESCO Finland
Anterior decompression of cervical spine with insertion of interbody fixating implant
74.1
19.7
22
*
ABC66
NOMESCO Finland
Decompression of lumbal spinal channel
13.3
19.7
34
26
M50.2
ICD-10 Finland
Other cervical disc displacement
19.6
19.5
29
15
A10BA02
ATC
metformin; oral
1.6
19.5
595
4083
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.9
19.5
81
213
H3603, E103
ICD-10 Finland
NA
7.4
19.5
46
63
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.9
19.4
80
209
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
19.4
253
1317
WX725
NOMESCO Finland
Noninvasive ventilation
2.8
19.3
130
486
N05AH04
ATC
quetiapine; oral
1.9
19.2
327
1881
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
6.7
19.2
49
75
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
19.1
121
437
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
19.0
144
578
B01AC04
ATC
clopidogrel; oral
1.9
19.0
307
1732
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
7.4
19.0
45
62
NAU20
NOMESCO Finland
Removal of internal fixation device from spine or neck
14.9
18.9
31
21
M86.6
ICD-10 Finland
Other chronic osteomyelitis
16.0
18.8
30
19
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.9
18.8
78
205
M02AA07
ATC
piroxicam; topical
1.5
18.7
782
5785
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.0
18.7
112
388
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.2
18.7
98
311
P01AB01
ATC
metronidazole; oral, rectal
1.5
18.7
807
6014
9211
FHL
Exploration or removal of diskusprolapse
4.0
18.6
76
197
G95.2
ICD-10 Finland
Cord compression, unspecified
100.9
18.6
20
*
N06AB10
ATC
escitalopram; oral
1.8
18.5
390
2401
T89
ICPC
Diabetes insulin dependent
3.1
18.5
103
342
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
4.0
18.4
74
189
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
18.4
147
609
NA3CM
NOMESCO Finland
Lumbar spine extensive MRI examination with 3 Tesla magnet
19.5
18.2
27
14
G04BD12
ATC
mirabegron; oral
2.0
18.0
231
1192
U04
ICPC
Incontinence urine
2.9
18.0
110
388
W19
ICD-10 Finland
Unspecified fall
2.1
18.0
214
1071
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
18.0
220
1112
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
18.0
272
1499
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
17.9
186
875
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
17.9
172
782
J02AC01
ATC
fluconazole; systemic
1.5
17.9
761
5640
SPAT1310
SPAT
Counselling related to known health issue
1.6
17.9
658
4711
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
17.8
478
3158
TAB20
NOMESCO Finland
Epidural puncture
7.4
17.7
42
58
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
17.6
172
789
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
17.6
578
4023
J01CA04
ATC
amoxicillin; systemic
1.5
17.5
1672
14697
M50.8
ICD-10 Finland
Other cervical disc disorders
10.8
17.4
33
31
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
29.0
17.4
23
8
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
29.0
17.4
23
8
C07AB07
ATC
bisoprolol; oral
1.5
17.4
988
7783
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.4
17.4
84
251
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
17.4
369
2276
R4180
NOMESCO Finland
Podiatric therapy
6.8
17.3
43
64
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
3.2
17.3
92
296
SPAT1211
SPAT
Application of soft bandage
2.1
17.3
211
1069
H04AA01
ATC
glucagon; nasal, parenteral
4.2
17.2
66
162
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
17.0
175
823
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
16.9
328
1966
ZXD35
NOMESCO Finland
Usual procedure
3.0
16.9
99
340
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
6.6
16.9
43
66
B01AB05
ATC
enoxaparin; parenteral
1.5
16.8
642
4623
ZXC95
NOMESCO Finland
Use of surgical navigator
5.7
16.8
48
86
R35
ICD-10 Finland
Polyuria
2.3
16.7
155
691
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.3
16.7
155
692
G992, M501
ICD-10 Finland
NA
+∞
16.7
16
*
G83.4
ICD-10 Finland
Cauda equina syndrome
12.8
16.6
29
23
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
16.5
159
724
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
16.4
970
7673
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.1
16.4
44
73
SPAT1312
SPAT
General health counselling
1.5
16.3
630
4545
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
7.8
16.3
37
48
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
16.3
173
824
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.8
16.3
302
1780
N07BC02
ATC
methadone; systemic
11.2
16.2
30
27
M01AE51
ATC
ibuprofen, combinations; systemic
4.2
16.2
62
152
X58
ICD-10 Finland
Exposure to other specified factors
1.8
16.2
301
1777
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
6.8
16.0
40
60
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.0
16.0
94
324
R03AC02
ATC
salbutamol; inhalant
1.4
16.0
1052
8484
G55.1
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders
6.5
16.0
41
64
N05CD07
ATC
temazepam; oral
1.9
16.0
268
1528
TAC99
NOMESCO Finland
Other blockade for chronic pain
9.0
15.9
33
37
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
15.8
240
1321
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
60.4
15.8
18
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
15.7
169
810
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.5
15.7
129
541
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
15.7
299
1780
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.4
15.7
77
234
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
7.6
15.6
36
48
N29
ICPC
Neurological sympt/complt other
4.3
15.6
57
134
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.9
15.6
99
357
L15
ICPC
Knee symptom/complaint
1.6
15.5
418
2749
NA3CF
NOMESCO Finland
Lumbar spine extensive MRI examination with median intensity magnet
11.8
15.5
28
24
S14.1
ICD-10 Finland
Other and unspecified injuries of cervical spinal cord
161.0
15.5
16
*
M47.0
ICD-10 Finland
Anterior spinal and vertebral artery compression syndromes
161.0
15.5
16
*
M79.7
ICD-10 Finland
Fibromyalgia
3.2
15.5
83
269
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.1
15.5
176
864
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
15.4
311
1881
R07.3
ICD-10 Finland
Other chest pain
2.0
15.4
199
1028
J01EA01
ATC
trimethoprim; systemic
1.6
15.4
475
3240
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
6.6
15.4
39
60
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
5.9
15.3
42
72
S06.0
ICD-10 Finland
Concussion
2.0
15.2
210
1116
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
15.2
1425
12257
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.8
15.1
254
1449
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
15.1
157
741
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
15.1
613
4460
G56.4
ICD-10 Finland
Causalgia
11.9
15.0
27
23
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.1
15.0
58
144
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
14.0
15.0
25
18
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
15.0
179
896
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
10.9
15.0
28
26
E66.00
ICD-10 Finland
Metabolic syndrome
2.4
14.9
133
583
NA2AD
NOMESCO Finland
Thoracic spine CT examination
7.7
14.9
34
45
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
14.9
358
2283
R55
ICD-10 Finland
Syncope and collapse
1.9
14.8
218
1185
A02BA02
ATC
ranitidine; systemic
1.6
14.7
410
2721
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
2.2
14.7
155
737
K59.0
ICD-10 Finland
Constipation
2.5
14.7
120
504
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.0
14.6
183
934
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.6
14.6
65
183
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
14.6
14
*
ABD40
NOMESCO Finland
Implantation of spinal injection device
+∞
14.6
14
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.3
14.5
131
579
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
14.5
128
559
ZXA00
NOMESCO Finland
Right side
1.5
14.4
567
4085
J01AA02
ATC
doxycycline; systemic
1.5
14.4
1652
14691
Z01.9
ICD-10 Finland
Special examination, unspecified
2.3
14.4
132
587
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.2
14.3
75
240
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.9
14.3
58
151
H3600, E103
ICD-10 Finland
NA
5.5
14.2
41
75
H25.8
ICD-10 Finland
Other senile cataract
1.9
14.2
219
1212
WX002
NOMESCO Finland
Sedation and analgesia
1.6
14.2
430
2914
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.5
14.2
66
193
C01DA14
ATC
isosorbide mononitrate; oral
1.7
14.1
293
1789
ZXA10
NOMESCO Finland
Bilateral
1.6
14.0
376
2467
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
14.0
405
2711
J01FA06
ATC
roxithromycin; oral
1.4
14.0
809
6311
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.8
13.8
57
151
R51
ICD-10 Finland
Headache
2.5
13.8
105
425
WX882
NOMESCO Finland
High dependency care
3.2
13.7
71
225
S29
ICPC
Skin symptom/complaint other
1.7
13.7
342
2197
J01FA09
ATC
clarithromycin; systemic
1.5
13.7
622
4614
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.8
13.7
89
328
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
13.7
1118
9285
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
13.7
548
3957
G04CA02
ATC
tamsulosin; oral
1.5
13.7
474
3312
H02AB04
ATC
methylprednisolone; systemic
1.7
13.6
306
1909
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
13.6
1914
17631
205
Kela drug reimbursment
Chronic hypertension
1.5
13.6
563
4096
A10BH01
ATC
sitagliptin; oral
1.9
13.6
201
1093
Z2446
NOMESCO Finland
Social worker
2.2
13.6
137
637
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
13.6
144
685
NA1BM
NOMESCO Finland
Cervical spine MRI examination with 3 Tesla magnet
14.8
13.6
22
15
9212
FHL
Other posterior root decompression surgery (eg laminectomy, Gill)
8.0
13.6
30
38
G90.2
ICD-10 Finland
Horner syndrome
+∞
13.6
13
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
13.6
13
*
NHQ40
NOMESCO Finland
Amputation of toe
4.1
13.5
52
129
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
13.5
118
512
R15
ICD-10 Finland
Faecal incontinence
3.2
13.5
69
217
NA1BG
SPAT
NA
7.5
13.4
31
42
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
13.4
89
333
G45.3
ICD-10 Finland
Amaurosis fugax
18.3
13.4
20
11
M50
ICD-10 Finland
Cervical disc disorders
7.0
13.3
32
46
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
13.9
13.2
22
16
ZZH31
NOMESCO Finland
Bone allograft, small pieces
6.1
13.2
35
58
Z3231
NOMESCO Finland
Registered nurse
1.5
13.1
554
4043
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
13.1
280
1721
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
13.1
455
3179
SPAT1260
SPAT
Consultation of another employee
1.6
13.0
365
2420
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
13.0
562
4121
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
13.0
109
465
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
10.1
13.0
25
25
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
3.2
12.9
66
208
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
12.9
158
802
G04BD08
ATC
solifenacin; oral
2.1
12.9
151
753
A01AB09
ATC
miconazole; local oral
2.0
12.8
176
934
L84
ICPC
Back syndrome without radiat pain
2.5
12.8
99
404
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.7
12.8
56
156
L29
ICPC
Musculoskeletal sympt/complt other
2.0
12.8
161
826
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.5
12.8
58
167
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
12.8
122
556
N03AF02
ATC
oxcarbazepine; oral
3.0
12.7
71
238
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
12.7
322
2077
C10AA05
ATC
atorvastatin; oral
1.4
12.7
763
5970
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
4.6
12.7
43
95
SPAT1167
SPAT
Insertion of urinary catheter
2.8
12.6
79
285
R60.9
ICD-10 Finland
Oedema, unspecified
2.5
12.6
103
431
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
15.5
12.6
20
13
A10BH05
ATC
linagliptin; oral
2.5
12.6
101
421
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
7.9
12.6
28
36
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
12.6
149
747
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
12.5
216
1240
NF1DA
NOMESCO Finland
X-ray of hips
3.2
12.5
64
202
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
12.5
12
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
12.5
190
1044
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
24.4
12.5
17
7
J37.0
ICD-10 Finland
Chronic laryngitis
2.9
12.5
73
253
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
6.3
12.4
32
51
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
12.4
456
3224
Z01.2
ICD-10 Finland
Dental examination
1.4
12.4
785
6189
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
12.4
143
709
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
3.6
12.3
54
151
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
3.6
12.3
54
151
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
12.3
67
221
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
12.3
74
261
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.4
12.3
105
452
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.8
12.3
230
1360
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.6
12.3
55
157
M41.5
ICD-10 Finland
Other secondary scoliosis
14.4
12.3
20
14
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.8
12.2
40
85
M54.8
ICD-10 Finland
Other dorsalgia
2.6
12.2
88
345
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
12.2
122
565
G04CA01
ATC
alfuzosin; oral
1.7
12.2
252
1534
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
6.4
12.1
31
49
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.9
12.1
49
128
H02AB07
ATC
prednisone; oral
1.7
12.1
296
1887
SPAT1255
SPAT
Intravenous administration of medicine
2.1
12.1
143
715
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
12.1
131
630
WZA90
NOMESCO Finland
Other doctors statement
1.5
12.1
449
3178
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.6
12.1
41
91
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.2
12.0
62
197
J01MA14
ATC
moxifloxacin; systemic
1.9
11.9
190
1064
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.8
11.9
49
130
R50.9
ICD-10 Finland
Fever, unspecified
1.7
11.9
272
1702
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
11.9
97
409
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
11.9
62
199
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
11.9
391
2693
WX892
NOMESCO Finland
Monitored bed care
2.0
11.8
160
845
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.2
11.8
122
575
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
8.4
11.8
25
30
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
11.8
155
808
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
11.7
192
1085
M19.9
ICD-10 Finland
Arthrosis, unspecified
2.6
11.7
86
342
WX290
NOMESCO Finland
Other blockade of nerve
1.4
11.7
827
6634
M77.1
ICD-10 Finland
Lateral epicondylitis
2.0
11.7
146
745
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
11.7
262
1633
N30.9
ICD-10 Finland
Cystitis, unspecified
2.3
11.6
103
451
M53.2
ICD-10 Finland
Spinal instabilities
6.0
11.6
31
52
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
11.6
1130
9560
R03BB04
ATC
tiotropium bromide; inhalant
1.8
11.6
210
1224
G82.0
ICD-10 Finland
Flaccid paraplegia
65.3
11.6
13
*
R5599
NOMESCO Finland
Other rehabilitation service
3.0
11.6
67
230
ABC04
NOMESCO Finland
Percutaneous endoscopic discectomy for thoracic intervertebral disc displacement
+∞
11.5
11
*
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
4.8
11.5
37
78
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
11.4
97
418
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
3.7
11.4
49
136
J01CA08
ATC
pivmecillinam; oral
1.4
11.3
672
5219
C10AA01
ATC
simvastatin; oral
1.4
11.3
865
7019
R39.1
ICD-10 Finland
Other difficulties with micturition
2.7
11.3
76
288
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
3.6
11.3
50
142
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.6
11.3
38
84
E66.8
ICD-10 Finland
Other obesity
2.3
11.2
106
480
N18.8
ICD-10 Finland
Other chronic renal failure
2.9
11.2
66
230
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.7
11.2
74
277
SPAT1104
SPAT
Monitoring of emergency patient
2.0
11.2
140
715
ZXA05
NOMESCO Finland
Left side
1.5
11.2
509
3757
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.4
11.2
53
159
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
11.1
71
261
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
11.1
1031
8632
F34.1
ICD-10 Finland
Dysthymia
2.7
11.1
77
295
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
11.1
411
2902
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
11.1
103
464
SPAT1097
SPAT
Recording of ECG
1.6
11.1
301
1975
R03BA05
ATC
fluticasone; inhalant
1.6
11.0
344
2335
D17
ICPC
Incontinence of bowel
6.1
11.0
29
48
R02
ICPC
Shortness of breath/dyspnoea
1.7
10.9
233
1431
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
10.9
170
941
M40.1
ICD-10 Finland
Other secondary kyphosis
43.5
10.9
13
*
J01FA10
ATC
azithromycin; systemic
1.4
10.9
1108
9399
D12
ICPC
Constipation
2.6
10.9
76
293
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
10.9
1239
10702
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
5.3
10.9
32
61
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.6
10.9
47
131
R52.0
ICD-10 Finland
Acute pain
2.9
10.9
65
230
9201
FHL
Anterior decompression surgery (also includes dees)
12.0
10.8
19
16
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
10.8
719
5685
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
10.8
56
180
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
4.0
10.8
42
107
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
10.8
650
5056
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.7
10.7
71
265
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
10.7
522
3902
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
10.7
192
1120
NAW00
NOMESCO Finland
Repair of wound dehiscence in surgery of spine or neck
21.6
10.7
15
7
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.9
10.7
147
783
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
10.7
119
582
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.8
10.6
67
244
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.6
10.6
75
292
K02.1
ICD-10 Finland
Caries of dentine
1.3
10.6
1089
9235
NA1BD
NOMESCO Finland
Extensive cervical spine CT examination
60.3
10.6
12
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.9
10.6
150
804
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
10.6
125
624
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.8
10.6
185
1067
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
10.5
67
246
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
10.5
785
6326
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
10.5
197
1161
Z71.8
ICD-10 Finland
Other specified counselling
1.5
10.5
428
3084
NBG10
NOMESCO Finland
Acromioplastia
2.7
10.5
71
271
ZXE00
NOMESCO Finland
One hour or less
1.4
10.5
775
6234
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.7
10.5
207
1244
M04AA01
ATC
allopurinol; systemic
1.6
10.5
258
1649
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
10.4
135
701
L16
ICPC
Ankle symptom/complaint
1.8
10.4
191
1118
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.3
10.4
92
402
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
5.2
10.4
31
60
ABC13
NOMESCO Finland
Microsurgical excision of thoracic intervertebral disc displacement
110.5
10.4
11
*
G992, D321
ICD-10 Finland
NA
+∞
10.4
10
*
N05CF02
ATC
zolpidem; oral
1.5
10.4
337
2304
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.5
10.4
47
136
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
4.4
10.4
36
82
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
10.4
311
2092
NAG99
NOMESCO Finland
Other excision, reconstruction or fusion of joints of spine, unspecified
32.7
10.3
13
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.6
10.3
45
127
M01AX05
ATC
glucosamine; oral
1.5
10.3
393
2793
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.5
10.2
47
138
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
10.2
191
1129
G04BD04
ATC
oxybutynin; oral, transdermal
2.1
10.2
111
537
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
3.8
10.2
42
113
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
2.1
10.2
111
538
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.2
10.2
52
166
SPAT1325
SPAT
Vaccination
1.4
10.1
653
5127
R01AD08
ATC
fluticasone; nasal
1.4
10.1
533
4036
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
4.8
10.1
32
67
R06AE07
ATC
cetirizine; oral
1.4
10.0
820
6693
R32
ICD-10 Finland
Unspecified urinary incontinence
2.9
10.0
59
207
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.9
10.0
138
736
AB3CB
NOMESCO Finland
Lumbar myelography
40.2
10.0
12
*
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.4
10.0
86
372
M01AB01
ATC
indometacin; systemic, rectal
1.8
9.9
166
946
NG2AA
NOMESCO Finland
Patella X-ray examination
2.6
9.9
70
272
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
3.2
9.9
50
158
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.4
9.9
86
374
SPAT1172
SPAT
Guidance concerning hydration
3.3
9.9
49
153
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
9.9
130
678
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
12.2
9.8
17
14
A04
ICPC
Weakness/tiredness general
1.7
9.8
222
1383
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
9.8
113
560
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.2
9.8
29
56
WX213
NOMESCO Finland
Lower leg blockade
5.4
9.8
28
52
M99.3
ICD-10 Finland
Osseous stenosis of neural canal
8.8
9.8
20
23
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
9.8
124
641
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.8
9.8
162
919
R03DC03
ATC
montelukast; oral
1.6
9.7
289
1938
N07BA03
ATC
varenicline; oral
2.1
9.7
105
507
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.8
9.7
179
1051
C07AB02
ATC
metoprolol; systemic
1.5
9.7
386
2763
U07
ICPC
Urine symptom/complaint other
2.0
9.7
118
597
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.7
9.7
65
247
AB5CT
NOMESCO Finland
Blockage of nerv root with CT guidance
6.8
9.6
23
34
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
9.6
187
1119
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
15.1
9.5
15
10
J01CF05
ATC
flucloxacillin; systemic
2.3
9.5
83
362
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.9
9.5
145
801
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
9.5
312
2140
G82.4
ICD-10 Finland
Spastic tetraplegia
100.4
9.4
10
*
XA402
NOMESCO Finland
ENMG
2.7
9.4
61
228
J01MA01
ATC
ofloxacin; systemic
1.7
9.3
178
1057
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
5.6
9.3
26
47
A07EC01
ATC
sulfasalazine; oral, rectal
1.8
9.3
162
932
R01AD09
ATC
mometasone; nasal
1.3
9.3
837
6911
D07AC01
ATC
betamethasone; topical
1.4
9.3
654
5195
M51.2
ICD-10 Finland
Other specified intervertebral disc displacement
6.9
9.3
22
32
A03FA02
ATC
cisapride; oral, rectal
1.8
9.3
151
853
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
9.3
109
546
TK800
NOMESCO Finland
Hemodialysis
2.9
9.2
53
183
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
9.2
139
768
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.0
9.2
50
168
GD1AD
NOMESCO Finland
Thorax CT examination
2.1
9.2
97
466
7240B
ICD-9 Finland
Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]
6.7
9.1
22
33
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
9.1
304
2092
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
9.1
179
1073
WX320
NOMESCO Finland
Spinalanesthesy
1.4
9.1
445
3317
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.8
9.1
156
896
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
9.1
101
496
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.5
9.0
66
265
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.5
9.0
66
265
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
36.8
9.0
11
*
NH1AD
NOMESCO Finland
Ankle and foot CT
2.9
9.0
52
180
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
9.0
65
258
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.9
9.0
53
187
C09AA05
ATC
ramipril; oral
1.4
9.0
466
3510
N06AX12
ATC
bupropion; oral
2.1
8.9
98
478
TAD08
NOMESCO Finland
Sympathetic block on sacral Level
18.7
8.9
13
7
A12AA04
ATC
calcium carbonate; oral
3.6
8.9
38
106
G04BD11
ATC
fesoterodine; oral
2.5
8.9
68
279
E0000UV
ATC
NA
1.3
8.9
728
5918
FN1AD
NOMESCO Finland
CT of coronary arteries
3.5
8.9
40
117
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
8.9
315
2199
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.0
8.9
110
563
A10AE06
ATC
insulin degludec; parenteral
2.6
8.8
64
255
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
8.8
407
2998
R31
ICD-10 Finland
Unspecified haematuria
1.7
8.8
193
1194
S01.0
ICD-10 Finland
Open wound of scalp
1.8
8.8
145
822
ZZA00
NOMESCO Finland
Split skin graft
2.5
8.8
67
275
WW502
NOMESCO Finland
Autotransfusion
5.9
8.7
23
39
C10AC01
ATC
colestyramine; oral
2.7
8.7
59
224
KED33
NOMESCO Finland
Transurethral incision of prostate
3.7
8.7
36
98
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.2
8.7
89
421
UDC00
NOMESCO Finland
Ear microscopy
1.8
8.7
142
801
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
8.7
119
631
WX722
NOMESCO Finland
PEEP
2.1
8.7
102
509
N99
ICPC
Neurological disease other
4.2
8.7
31
74
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
2.9
8.7
50
173
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
8.7
514
3960
P03
ICPC
Feeling depressed
1.8
8.6
140
790
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
8.6
473
3594
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
7.7
8.6
19
25
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.9
8.6
50
174
H02AB09
ATC
hydrocortisone; systemic
2.8
8.6
52
187
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
8.6
199
1253
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
8.6
154
900
A02BC04
ATC
rabeprazole; oral
1.7
8.6
171
1031
R26.0
ICD-10 Finland
Ataxic gait
11.6
8.6
15
13
N06AX26
ATC
vortioxetine; oral
2.1
8.5
95
467
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
3.7
8.5
35
95
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.1
8.5
44
143
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
8.5
90
433
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
8.5
72
313
318
Kela drug reimbursment
Teriparatide
6.4
8.5
21
33
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
8.4
151
882
J04AB02
ATC
rifampicin; systemic
3.7
8.4
35
96
G04BD07
ATC
tolterodine; oral
2.1
8.4
94
463
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.0
8.4
45
150
N03A
ATC
ANTIEPILEPTICS
12.8
8.4
14
11
R27.0
ICD-10 Finland
Ataxia, unspecified
7.9
8.4
18
23
ABC23
NOMESCO Finland
Open discectomy of thoracic spine
+∞
8.3
8
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
8.3
8
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.6
8.3
35
97
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
8.3
224
1465
M65.3
ICD-10 Finland
Trigger finger
2.1
8.3
89
431
M02AA10
ATC
ketoprofen; topical
1.5
8.3
314
2219
K30
ICD-10 Finland
Functional dyspepsia
1.7
8.2
184
1143
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.8
8.2
144
835
M01AB08
ATC
etodolac; oral
1.7
8.2
154
912
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
8.2
1351
12066
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
8.2
366
2675
R4110
SPAT
NA
2.5
8.2
63
259
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
6.5
8.2
20
31
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.5
8.2
61
249
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.7
8.2
54
206
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.6
8.1
35
99
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
8.1
210
1359
A11CC03
ATC
alfacalcidol; systemic
2.9
8.1
47
164
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
8.1
785
6520
L09
ICPC
Arm symptom/complaint
2.1
8.1
85
409
ZZH30
NOMESCO Finland
Bone allograft
33.5
8.1
10
*
NA7DM
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with 3 Tesla magnet
33.5
8.1
10
*
J01MA06
ATC
norfloxacin; oral
1.5
8.1
245
1650
K05.31
ICD-10 Finland
Periodontitis pronounced
1.6
8.1
195
1239
Z43.5
ICD-10 Finland
Attention to cystostomy
6.8
8.1
19
28
C08CA02
ATC
felodipine; oral
1.7
8.0
179
1112
NAW10
NOMESCO Finland
Reoperation for superficial infection in in surgery of spine or neck
22.1
8.0
11
5
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.9
8.0
47
166
SPAT1151
SPAT
Treatment of major wounds
3.4
8.0
36
106
XQ800
NOMESCO Finland
Prick test
1.8
8.0
136
782
R06.4
ICD-10 Finland
Hyperventilation
3.3
8.0
38
117
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
8.0
186
1171
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.0
7.9
99
510
E87.6
ICD-10 Finland
Hypokalaemia
2.4
7.9
65
278
CKC15
NOMESCO Finland
Panretinal photocoagulation
4.9
7.9
24
49
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
7.9
61
252
R03AK11
ATC
formoterol and fluticasone; inhalant
2.6
7.8
54
209
C08CA13
ATC
lercanidipine; oral
1.5
7.8
248
1686
U28
ICPC
Limited function/disability (U)
4.3
7.8
27
63
N05BA12
ATC
alprazolam; oral
1.6
7.8
194
1241
H03AA01
ATC
levothyroxine sodium; systemic
1.4
7.8
411
3095
PD5AD
NOMESCO Finland
CT of aorta
3.2
7.8
38
119
R41.0
ICD-10 Finland
Disorientation, unspecified
2.6
7.8
52
200
XF402
NOMESCO Finland
ECG with work load test
1.6
7.8
218
1440
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
3.2
7.8
39
125
Z2445
NOMESCO Finland
Psychologist
2.3
7.8
69
306
M01AX01
ATC
nabumetone; oral
2.0
7.8
91
457
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.9
7.7
30
78
SPAT1240
SPAT
Therapeutic discussion
1.7
7.7
171
1061
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.6
7.7
210
1376
S70.0
ICD-10 Finland
Contusion of hip
2.3
7.7
66
287
7221A
ICD-9 Finland
Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy
5.0
7.7
23
46
NA2BM
NOMESCO Finland
Thoracal spine MRI examination with 3 Tesla magnet
45.1
7.7
9
*
M14.6
ICD-10 Finland
Neuropathic arthropathy
15.1
7.7
12
8
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.9
7.7
117
646
A02BB01
ATC
misoprostol; oral
5.3
7.7
22
42
A10BB01
ATC
glibenclamide; oral
2.2
7.7
77
363
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
5.6
7.7
21
38
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.0
7.7
99
517
A99
ICPC
Disease/condition unspecnature/site
1.7
7.6
142
840
M10.9
ICD-10 Finland
Gout, unspecified
1.8
7.6
124
702
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
2.2
7.6
71
323
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
7.6
345
2529
N06AB06
ATC
sertraline; oral
1.6
7.6
187
1194
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
6.7
7.6
18
27
B01AF01
ATC
rivaroxaban; oral
1.5
7.6
225
1508
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
4.9
7.6
23
47
N02AJ13
ATC
tramadol and paracetamol; systemic
2.8
7.6
45
161
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
11.9
7.6
13
11
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
4.5
7.6
25
56
NA7BT
NOMESCO Finland
Injection to spinal facet joint with radiological guidance
6.2
7.5
19
31
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
10.1
7.5
14
14
M76.0
ICD-10 Finland
Gluteal tendinitis
3.1
7.5
39
128
WX212
NOMESCO Finland
Femoral plexus blockade
3.0
7.5
40
134
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
7.5
206
1354
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
7.1
7.5
17
24
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.1
7.5
17
24
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.8
7.5
126
720
A07AA02
ATC
nystatin; oral
1.8
7.5
121
686
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
7.5
137
808
A10BK03
ATC
empagliflozin; oral
1.8
7.5
133
774
R25.2
ICD-10 Finland
Cramp and spasm
2.7
7.4
49
187
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
7.4
306
2201
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
80.3
7.4
8
*
D33.43
ICD-10 Finland
Spinal cord
80.3
7.4
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
7.4
220
1473
M89.0
ICD-10 Finland
Algoneurodystrophy
5.0
7.4
22
44
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.4
603
4869
SPAT1279
SPAT
Preparation of immediate hospitalisation
4.2
7.4
26
62
M99.5
ICD-10 Finland
Intervertebral disc stenosis of neural canal
13.4
7.4
12
9
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
3.5
7.4
32
92
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
7.3
158
976
NB1AD
NOMESCO Finland
Shoulder CT examination
3.1
7.3
38
125
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.5
7.3
228
1546
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
7.3
108
592
F32.1
ICD-10 Finland
Moderate depressive episode
2.1
7.3
83
411
G992, C795
ICD-10 Finland
NA
+∞
7.3
7
*
G95.1
ICD-10 Finland
Vascular myelopathies
+∞
7.3
7
*
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.3
7.3
66
296
N06
ICPC
Sensation disturbance other
4.2
7.3
26
63
T91.1
ICD-10 Finland
Sequelae of fracture of spine
9.4
7.3
14
15
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
4.0
7.3
27
68
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.8
7.3
117
660
N06AB03
ATC
fluoxetine; oral
1.5
7.3
233
1590
M01AH03
ATC
valdecoxib; oral
1.7
7.3
133
781
C01CA24
ATC
epinephrine; parenteral
1.9
7.2
104
566
NH2AA
NOMESCO Finland
Heel X-ray examination
5.2
7.2
21
41
M96.0
ICD-10 Finland
Pseudarthrosis after fusion or arthrodesis
6.2
7.2
18
29
H05AA02
ATC
teriparatide; parenteral
5.8
7.2
19
33
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
7.2
93
485
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
7.2
87
444
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.2
7.2
68
312
UJD02
NOMESCO Finland
Gastroscopy
2.0
7.2
91
472
H02.4
ICD-10 Finland
Ptosis of eyelid
2.4
7.2
57
241
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
3.7
7.2
29
79
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
7.2
111
621
B01AX06
ATC
[U] rivaroxaban; oral
2.6
7.1
48
186
B01AC07
ATC
dipyridamole; systemic
2.3
7.1
63
281
RS221
NOMESCO Finland
NA
3.3
7.1
33
100
G62.8
ICD-10 Finland
Other specified polyneuropathies
4.4
7.1
24
55
A10BJ02
ATC
liraglutide; parenteral
2.5
7.1
51
205
L60.0
ICD-10 Finland
Ingrowing nail
2.1
7.1
77
374
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.8
7.1
114
644
QDA10
NOMESCO Finland
Incision of skin of lower limb
5.0
7.1
21
42
KCV04
NOMESCO Finland
Distension of bladder with fluid
4.2
7.1
25
60
N06AX03
ATC
mianserin; oral
2.0
7.1
92
481
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.3
7.1
59
255
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.9
7.1
96
510
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
7.1
574
4629
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.6
7.0
49
191
ABC99
NOMESCO Finland
Other decompressive operation on spinal cord or nerve root
8.8
7.0
14
16
A10BB12
ATC
glimepiride; oral
1.7
7.0
128
753
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
7.0
180
1163
C09AA02
ATC
enalapril; systemic
1.4
7.0
376
2836
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.3
7.0
24
56
J02AC02
ATC
itraconazole; systemic
1.4
7.0
327
2408
M75.8
ICD-10 Finland
Other shoulder lesions
2.3
7.0
64
288
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.9
7.0
40
138
H36.00
ICD-10 Finland
Diabetic background retinopathy
3.3
7.0
33
102
N05AA02
ATC
levomepromazine; systemic
2.0
6.9
81
408
M48
ICD-10 Finland
Other spondylopathies
6.3
6.9
17
27
NGQ20
NOMESCO Finland
Amputation of lower leg
6.3
6.9
17
27
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.4
6.9
31
92
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
5.5
6.9
19
35
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
6.9
125
735
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
6.9
467
3663
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
6.9
408
3129
R00.2
ICD-10 Finland
Palpitations
1.8
6.9
121
702
H3602, E103
ICD-10 Finland
NA
13.8
6.9
11
8
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
13.8
6.9
11
8
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
6.9
130
775
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
6.9
425
3287
N03AG01
ATC
valproic acid; systemic, rectal
1.9
6.9
95
511
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.0
6.9
78
389
S92.3
ICD-10 Finland
Fracture of metatarsal bone
2.2
6.8
63
285
E000001
ATC
NA
1.4
6.8
362
2728
A29
ICPC
General symptom/complaint other
1.6
6.8
193
1278
N32.0
ICD-10 Finland
Bladder-neck obstruction
4.4
6.8
23
53
NAG61
NOMESCO Finland
Posterior fusion of lumbar spine without fixation
8.3
6.8
14
17
R03BA02
ATC
budesonide; inhalant
1.4
6.8
303
2212
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
6.8
77
381
SPAT1050
SPAT
Extensive neurological examination
2.7
6.8
44
166
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
2.2
6.8
63
288
SPAT1058
SPAT
PEF monitoring instruction
1.6
6.8
149
928
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
40.2
6.8
8
*
XF404
NOMESCO Finland
Ambulatory ECG
1.6
6.8
166
1060
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.1
6.8
70
335
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.8
6.8
107
600
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
3.0
6.7
35
116
I95.1
ICD-10 Finland
Orthostatic hypotension
2.3
6.7
58
257
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
6.7
63
290
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.0
6.7
36
122
Z49.2
ICD-10 Finland
Other dialysis
4.7
6.7
21
45
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
2.3
6.7
59
261
Z56.5
ICD-10 Finland
Uncongenial work
22.6
6.7
9
*
T92.4
ICD-10 Finland
Sequelae of injury of nerve of upper limb
22.6
6.7
9
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
6.7
200
1344
R06.5
ICD-10 Finland
Mouth breathing
1.6
6.7
162
1033
AA1AA
NOMESCO Finland
Head X-ray examination
4.9
6.7
20
41
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.7
474
3744
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.6
6.7
173
1124
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.1
6.6
74
366
S91.3
ICD-10 Finland
Open wound of other parts of foot
2.5
6.6
47
187
7227A
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]
6.4
6.6
16
25
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
6.6
70
340
R03BA08
ATC
ciclesonide; inhalant
1.6
6.6
149
931
G63.2
ICD-10 Finland
Diabetic polyneuropathy
5.2
6.6
19
37
WX872
NOMESCO Finland
Intensive care
1.9
6.6
97
533
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
6.6
115
667
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
5.9
6.6
17
29
SPAT1234
SPAT
Support of social functional capacity
2.0
6.6
84
436
7211A
ICD-9 Finland
Spondylosis and allied disorders, Cervical spondylosis with myelopathy
12.3
6.6
11
9
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.6
6.6
27
75
AEA24
NOMESCO Finland
Removal of spinal stimulation elecrode
8.7
6.5
13
15
SFA00
NOMESCO Finland
Small filling
1.5
6.5
226
1567
L89
ICPC
Osteoarthrosis of hip
2.1
6.5
66
312
SPAT1284
SPAT
Extensive health certificate
2.3
6.5
54
235
U13
ICPC
Bladder symptom/complaint other
2.3
6.5
58
258
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.2
6.5
62
288
XA800
NOMESCO Finland
Neuropsychological investigation
2.0
6.5
75
374
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
3.4
6.5
29
86
S76
ICPC
Skin infection other
1.9
6.5
90
484
P01BA02
ATC
hydroxychloroquine; oral
1.6
6.5
151
952
H26.02
ICD-10 Finland
Presenil cataract
2.3
6.5
58
259
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
6.5
80
413
D07AC13
ATC
mometasone; topical
1.3
6.5
532
4288
G44.8
ICD-10 Finland
Other specified headache syndromes
4.1
6.5
23
56
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.5
6.5
46
183
A02BA04
ATC
nizatidine; systemic
1.6
6.5
143
890
A10BJ06
ATC
semaglutide; parenteral
2.2
6.5
64
302
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
6.5
73
364
M46.4
ICD-10 Finland
Discitis, unspecified
5.3
6.5
18
34
ABC33
NOMESCO Finland
Decompression of thoracic nerve roots
70.0
6.4
7
*
G93.0
ICD-10 Finland
Cerebral cysts
70.0
6.4
7
*
NA1DM
NOMESCO Finland
Cervical spine very extensive MRI examination with 3 Tesla magnet
70.0
6.4
7
*
H53.2
ICD-10 Finland
Diplopia
2.3
6.4
56
250
K08.3
ICD-10 Finland
Retained dental root
1.7
6.4
129
783
R03AK08
ATC
formoterol and beclometasone; inhalant
2.1
6.4
70
344
XX1VW
NOMESCO Finland
Written report from radiologist
4.7
6.4
20
43
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
6.4
496
3965
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.6
6.4
156
995
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.8
6.4
95
525
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.2
6.4
60
276
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.8
6.4
97
541
T90.5
ICD-10 Finland
Sequelae of intracranial injury
3.8
6.4
25
67
L05
ICPC
Flank/axilla symptom/complaint
1.8
6.4
100
560
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.0
6.3
33
110
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.7
6.3
41
154
NC1CG
NOMESCO Finland
Elbow and forearm extensive MRI examination with high intensity magnet
6.6
6.3
15
23
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
2.2
6.3
57
257
D07AD01
ATC
clobetasol; topical
1.4
6.3
275
1997
NBB20
NOMESCO Finland
Primary total prosthetic replacement of humero-scapular joint
3.5
6.3
27
78
7225B
ICD-9 Finland
Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]
11.0
6.3
11
10
M86.8
ICD-10 Finland
Other osteomyelitis
11.0
6.3
11
10
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.5
6.3
45
181
XG466
NOMESCO Finland
Sleep oxymetry
2.0
6.3
71
352
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
3.6
6.3
26
73
G06.1
ICD-10 Finland
Intraspinal abscess and granuloma
18.1
6.3
9
5
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
2.9
6.3
36
126
G72.8
ICD-10 Finland
Other specified myopathies
2.9
6.3
34
117
ABE50
NOMESCO Finland
Occipitocervical decompression
+∞
6.3
6
*
G992, M513
ICD-10 Finland
NA
+∞
6.3
6
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
6.3
6
*
M471G
ICD-10 Finland
NA
+∞
6.3
6
*
G992, D434
ICD-10 Finland
NA
+∞
6.3
6
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
6.2
338
2551
J20
ICD-10 Finland
Acute bronchitis
1.6
6.2
170
1117
M01AC01
ATC
piroxicam; systemic, rectal
1.4
6.2
266
1923
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
6.2
127
772
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
26.7
6.2
8
*
WX202
NOMESCO Finland
Supraclavicular plexus blockade
3.0
6.2
32
106
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.5
6.2
189
1274
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.1
6.2
62
295
WX720
NOMESCO Finland
Own respiration
2.0
6.2
75
384
J34.2
ICD-10 Finland
Deviated nasal septum
1.8
6.2
99
561
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.2
6.2
59
274
M75
ICD-10 Finland
Shoulder lesions
1.9
6.2
81
426
L04AA01
ATC
[U] ciclosporin; systemic
3.1
6.2
31
101
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.1
6.2
62
296
TQW40
SPAT
NA
2.2
6.2
61
287
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.6
6.2
41
159
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
3.3
6.1
28
85
N06AX17
ATC
milnacipran; oral
3.3
6.1
28
85
L10
ICPC
Elbow symptom/complaint
1.9
6.1
83
444
D07AB08
ATC
desonide; topical
1.5
6.1
185
1245
M05BA07
ATC
risedronic acid; oral
2.2
6.1
58
267
N06AA12
ATC
doxepin; systemic
1.8
6.1
102
587
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
6.1
139
874
C10AX09
ATC
ezetimibe; oral
1.5
6.1
202
1388
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
2.7
6.1
38
143
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.1
6.1
65
316
P20
ICPC
Memory disturbance
1.5
6.1
189
1284
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.9
6.1
82
436
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.9
6.1
33
114
WX308
NOMESCO Finland
Sacral anesthesy
8.6
6.1
12
14
R03DA04
ATC
theophylline; systemic, rectal
1.9
6.0
88
482
M01AB16
ATC
aceclofenac; oral
2.1
6.0
67
331
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.2
6.0
29
92
R5110
SPAT
NA
2.3
6.0
52
230

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
1436
8432
2.66
122.15
8.2
9.4
inr
1.2
1.3
4.27
370
2434
(3044640) Blood type and Crossmatch panel - Blood
1185
6502
2.57
113.56
3.1
2.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1110
5968
2.55
110.19
2.6
2.1
u/l
229.3
240.2
0.13
1049
5581
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1528
9639
2.52
105.73
5.3
4.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1765
12055
2.60
100.55
6.8
4.7
mmol/l
6.9
6.8
2.33
1705
11320
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1553
10210
2.39
92.82
8.8
6.9
mmol/l
1.2
1.2
0.93
1267
8618
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1421
9296
2.23
81.60
7.9
6.1
mmol/l
1.2
1.2
0.74
1271
8402
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
905
5002
2.27
77.97
3.1
2.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1232
7845
2.13
72.85
4.7
3.5
ng/l
121.5
52.0
0.59
942
5468
(3023368) Bacteria identified in Blood by Culture
953
5652
2.11
66.31
6.0
4.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
965
5813
2.08
63.83
4.7
3.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1942
15188
2.27
61.81
5.7
4.0
mm/h
14.4
12.3
6.48
1803
14016
(3037467) Urinalysis macro (dipstick) panel - Urine
1825
13956
2.15
61.06
6.5
4.2
—
—
—
0
0
(3013512) EKG study
1002
6248
2.01
59.11
5.1
3.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1035
6529
2.00
59.06
3.4
2.6
u/l
52.3
58.7
3.02
966
6009
(3024561) Albumin [Mass/volume] in Serum or Plasma
1307
9004
1.95
57.00
5.8
4.9
g/l
34.7
35.5
4.87
1207
8374
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1241
8422
1.94
56.38
2.3
2.0
pmol/l
95.1
94.9
0.05
673
4398
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2002
16181
2.21
53.54
9.5
7.6
u/l
80.9
78.8
0.65
1892
15249
(3031040) Bacteria [#/volume] in Urine by Automated count
1723
13193
1.99
53.27
6.7
4.3
e6/l
381.8
1742.7
1.45
25
184
(3042936) Bacteria identified in Isolate by Culture
567
2966
2.18
52.67
3.0
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1493
10946
1.91
51.92
6.4
6.4
umol/l
10.3
11.6
2.00
1409
10404
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
954
6051
1.93
51.83
3.1
3.0
ng/l
1157.9
1376.1
1.18
804
5151
(42870588) Differential panel, method unspecified - Blood
1065
7007
1.91
51.76
7.2
5.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
666
3742
2.06
51.09
2.0
1.7
nmol/l
1115.9
1181.4
0.99
503
2804
(3012095) Magnesium [Moles/volume] in Serum or Plasma
605
3372
2.05
46.89
3.5
3.4
mmol/l
0.8
0.8
0.30
557
3168
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
594
3319
2.04
45.55
2.1
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
732
4415
1.93
44.93
2.0
1.7
mg/l
1.1
1.2
0.83
549
3412
(3019225) pH of Specimen
425
2123
2.21
43.54
5.0
4.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1174
8277
1.79
43.19
2.7
2.2
nmol/l
77.4
77.9
0.24
1062
7414
(3021960) Folate [Moles/volume] in Serum or Plasma
758
4717
1.87
41.72
1.7
1.5
nmol/l
20.0
20.7
0.60
630
4014
(3003458) Phosphate [Moles/volume] in Serum or Plasma
503
2725
2.06
41.56
8.3
6.0
mmol/l
1.1
1.0
1.23
478
2535
(3003396) Base excess in Arterial blood by calculation
454
2375
2.11
41.15
6.8
7.6
mmol/l
1.1
1.1
0.17
371
1867
(3007853) Bacteria identified in Skin by Aerobe culture
452
2369
2.11
40.73
2.6
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
370
1792
2.25
40.70
2.3
2.1
nmol/l
337.1
373.7
3.34
333
1639
(3026782) Osmolality of Urine
670
4035
1.90
40.65
3.6
2.7
mosm/kgh2o
535.9
553.2
1.26
602
3416
(3019069) Monocytes/100 leukocytes in Blood
1305
9613
1.75
40.18
8.2
6.3
%
8.5
8.7
1.39
1229
8990
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
450
2376
2.09
39.68
6.9
7.6
kpa
5.2
5.1
1.32
431
2269
(3027801) Oxygen [Partial pressure] in Arterial blood
450
2376
2.09
39.68
6.8
7.6
kpa
13.4
12.2
3.65
430
2270
(3006504) Eosinophils/100 leukocytes in Blood
1298
9569
1.74
39.65
7.7
6.0
%
2.9
2.9
0.50
1221
8906
(3002030) Lymphocytes/100 leukocytes in Blood
1328
9855
1.75
39.61
7.8
6.1
%
26.6
27.6
2.71
1241
9160
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
789
5057
1.82
38.98
2.5
2.2
mg/l
3.1
3.0
0.29
671
4280
(3037522) Nuclear Ab [Titer] in Serum
484
2643
2.03
38.87
1.4
1.3
titre
470.8
490.8
0.08
96
568
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1873
15409
1.87
38.67
4.7
3.9
pmol/l
15.0
14.8
1.42
1699
13964
(3018010) Neutrophils/100 leukocytes in Blood
1305
9698
1.73
38.17
7.4
5.9
%
58.2
57.4
1.62
1222
9061
(3022096) Basophils/100 leukocytes in Blood
1263
9305
1.73
38.09
7.6
6.1
%
0.7
0.7
0.17
1185
8675
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
1057
7426
1.74
37.75
4.5
3.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
312
1453
2.31
37.52
1.8
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2304
20514
2.66
37.50
25.4
14.2
mg/l
22.6
24.6
2.47
2002
16201
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
699
4369
1.83
37.18
1.9
1.7
pmol/l
22518158.2
33416679.0
0.25
564
3618
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2155
18680
2.14
36.99
5.9
4.6
mu/l
1.9
2.1
1.04
1963
16982
(3009343) pH of Capillary blood
291
1325
2.35
36.83
4.6
3.6
ph
7.4
7.4
0.11
38
173
(3006315) Basophils [#/volume] in Blood
1353
10219
1.71
36.72
7.2
5.8
e9/l
0.0
0.0
1.57
1222
8785
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1677
13442
1.76
36.61
4.3
3.1
u/l
60.7
52.8
1.43
1560
12448
(3019198) Lymphocytes [#/volume] in Blood
1375
10439
1.71
36.53
7.3
5.9
e9/l
1.9
1.9
0.24
1255
9162
(3001604) Monocytes [#/volume] in Blood
1346
10171
1.70
36.29
7.2
5.8
e9/l
0.6
0.6
2.36
1216
8745
(3013115) Eosinophils [#/volume] in Blood
1387
10573
1.70
36.13
7.4
6.0
e9/l
0.2
0.2
2.73
1256
9232
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
576
3414
1.89
36.10
1.3
1.3
iu/ml
36.8
36.3
0.03
176
1108
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
292
1343
2.33
36.09
4.6
3.6
kpa
5.3
5.2
1.42
274
1246
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
421
2241
2.06
36.04
5.0
3.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
402
2122
2.07
35.14
7.0
8.0
%
96.0
95.5
0.85
388
2047
(3022948) Iron [Moles/volume] in Serum or Plasma
543
3201
1.89
34.41
3.2
2.5
umol/l
11.5
13.3
7.54
496
2965
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
277
1280
2.31
33.78
4.7
3.5
mmol/l
1.9
1.9
0.04
221
942
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
207
842
2.59
33.36
5.6
5.1
%
1.7
1.6
0.61
199
784
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1128
8267
1.67
33.01
3.7
2.8
ug/l
140.7
144.5
0.20
1025
7617
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
134
434
3.21
32.84
1.8
1.2
mg/l
658.4
544.5
0.76
127
404
(3020682) Albumin/Creatinine [Ratio] in Urine
960
6785
1.68
32.04
4.9
4.0
mg/mmol
15.2
8.4
2.68
659
4279
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
206
855
2.54
31.81
2.0
1.9
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
201
829
2.55
31.44
5.8
5.1
%
1.0
0.9
1.74
194
771
(3047181) Lactate [Moles/volume] in Blood
165
627
2.75
30.40
6.8
6.0
mmol/l
1.2
1.4
1.23
150
540
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
246
1129
2.31
30.38
8.7
10.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
772
5215
1.70
30.17
4.8
3.9
%
91.3
89.6
1.06
745
5092
(3022313) Gas panel - Capillary blood
219
961
2.40
29.95
5.1
3.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
494
2946
1.84
29.71
2.7
2.1
s
29.3
29.9
1.47
472
2851
(3000850) Epithelial cells [#/volume] in Urine
663
4312
1.73
29.68
3.4
2.5
e6/l
5.5
5.2
0.18
597
3778
(3020630) Protein [Mass/volume] in Serum or Plasma
334
1746
2.05
29.67
2.7
2.7
g/l
65.6
66.7
1.44
308
1602
(3044290) Cell count panel - Cerebral spinal fluid
115
362
3.28
29.53
1.8
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
179
722
2.59
29.29
2.5
2.4
ug/l
348.0
550.0
0.86
163
684
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
473
2794
1.86
29.28
3.4
2.6
%
20.7
23.4
3.54
392
2397
(3018572) Chloride [Moles/volume] in Blood
131
448
3.03
29.26
7.0
6.9
mmol/l
105.3
105.3
0.03
124
396
(3039000) Anion gap in Blood
131
448
3.03
29.26
7.0
6.9
mmol/l
10.4
11.4
2.71
124
396
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
457
2671
1.87
29.26
5.0
4.6
%
32.3
32.1
0.09
342
1759
(3002173) Hemoglobin [Mass/volume] in Arterial blood
363
1967
1.99
29.14
7.6
8.4
g/l
121.5
122.4
0.33
352
1890
(3019550) Sodium [Moles/volume] in Serum or Plasma
2348
21500
2.63
28.68
28.0
16.3
mmol/l
139.5
139.7
3.80
2313
20951
(3019060) Gas panel - Arterial blood
277
1368
2.15
28.54
5.1
4.7
—
—
—
0
0
(3015736) pH of Urine
1032
7588
1.62
28.48
4.0
3.3
—
5.6
—
0
7
(3005719) IgG [Mass/volume] in Serum or Plasma
297
1508
2.10
28.47
3.1
2.8
g/l
9.8
10.7
3.16
263
1372
(3004789) Transferrin [Mass/volume] in Serum or Plasma
491
2977
1.81
27.78
3.3
2.5
g/l
2.3
2.3
0.30
448
2756
(3023103) Potassium [Moles/volume] in Serum or Plasma
2348
21564
2.57
27.32
28.2
16.5
mmol/l
4.0
4.0
3.07
2312
20989
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
183
772
2.48
27.24
1.9
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
927
6695
1.61
27.21
3.9
3.2
mmol/l
7.3
7.6
1.50
760
5609
(3002582) Erythrocytes [#/volume] in Urine
877
6259
1.62
26.98
4.5
3.2
e6/l
225.5
90.0
0.49
754
4830
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
65
147
4.51
26.69
1.7
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1473
11893
1.58
26.59
9.9
9.2
e9/l
4.3
4.1
2.28
1337
10373
(3012516) Albumin [Mass/volume] in Urine
896
6450
1.61
26.48
4.1
3.3
mg/l
659.8
283.0
1.16
595
4067
(3009261) Glucose [Presence] in Urine by Test strip
1272
9940
1.57
26.38
4.8
3.6
estimate
0.0
0.0
1.34
254
1782
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
116
394
3.04
26.23
1.7
1.1
mmol/l
4.0
3.8
0.53
107
372
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
924
6717
1.60
26.12
3.3
3.2
u/l
33.4
35.4
0.42
872
6372
(3035350) Ketones [Presence] in Urine by Test strip
1257
9814
1.57
26.04
4.7
3.5
estimate
0.0
0.0
0.00
265
1817
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
196
872
2.35
25.92
1.9
2.0
ug/l
3.0
1.8
0.28
172
780
(3021601) Nitrite [Presence] in Urine by Test strip
1259
9840
1.57
25.91
6.4
4.8
estimate
0.0
0.0
0.50
270
1855
(3020779) Urea [Moles/volume] in Serum or Plasma
340
1873
1.94
25.84
10.1
7.7
mmol/l
10.0
10.1
0.12
328
1786
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
519
3270
1.74
25.51
1.3
1.2
u/ml
24.1
12.5
0.39
174
1258
(3030467) Casts [#/volume] in Urine by Automated count
809
5723
1.61
25.47
4.3
3.1
e6/l
0.3
0.5
1.86
686
4324
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
617
4088
1.68
25.15
1.3
1.2
u/ml
1.4
1.6
0.10
140
1066
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
110
372
3.05
25.06
1.7
1.2
e6/l
16.6
26.2
0.22
83
277
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
110
372
3.05
25.06
1.8
1.3
e6/l
379.7
1619.9
0.88
92
296
(3026493) Urate [Moles/volume] in Serum or Plasma
795
5625
1.61
24.89
3.2
2.7
umol/l
3424.4
5012.5
0.64
687
4897
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
59
131
4.59
24.79
1.6
1.2
mmol/l
2.2
2.2
0.03
52
123
(3008152) Bicarbonate [Moles/volume] in Arterial blood
254
1279
2.10
24.77
7.4
6.9
mmol/l
25.2
24.6
2.01
243
1188
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
185
823
2.35
24.46
5.7
3.8
mmol/l
25.1
24.8
0.58
177
766
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
402
2377
1.82
24.44
4.0
4.2
u/l
240.6
248.4
0.46
376
2250
(3004588) Protein electrophoresis panel - Serum or Plasma
277
1450
2.02
24.31
2.7
2.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
91
281
3.32
24.12
8.1
6.4
mg/l
11.3
11.5
0.12
85
264
(3015377) Calcium [Moles/volume] in Serum or Plasma
943
6988
1.56
24.00
3.0
3.5
mmol/l
2.3
2.4
1.15
792
6116
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
286
1534
1.98
23.39
5.4
3.9
ng/l
96.6
91.0
0.41
243
1339
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2152
19347
1.83
23.20
8.2
5.8
mmol/mol
41.9
40.0
12.16
2002
17851
(3018095) Leukocytes [#/volume] in Urine
963
7227
1.54
22.85
5.1
3.6
e6/l
150.2
112.6
0.28
786
5172
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
56
130
4.38
22.28
1.4
1.1
mg/l
46.4
38.3
0.71
48
108
(3000494) Fungus identified in Specimen by Culture
407
2492
1.76
21.81
1.7
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
54
127
4.32
21.14
1.3
1.0
mg/l
401.2
276.4
1.05
48
107
(40761511) CBC panel - Blood by Automated count
2310
21403
2.10
20.65
24.3
13.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
66
184
3.66
20.48
1.9
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
819
6046
1.53
20.38
5.9
4.1
ph
7.4
7.4
0.23
193
1150
(3007164) IgA [Mass/volume] in Serum or Plasma
542
3649
1.62
20.14
1.6
1.5
g/l
2.4
2.5
0.37
326
2240
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
155
700
2.29
19.77
1.6
1.6
titre
120.0
218.1
—
6
32
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
51
122
4.25
19.55
1.2
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
366
2256
1.73
18.97
2.1
2.3
ug/g
205.8
146.0
1.30
279
1811
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
105
407
2.65
18.62
1.8
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
229
1234
1.94
18.36
1.9
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
753
5566
1.51
18.19
4.3
3.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
211
1111
1.98
18.09
7.2
10.2
mmol/l
24.5
24.4
0.14
195
1045
(40768797) Stomach Pathology biopsy report
449
2963
1.63
17.88
1.3
1.2
—
—
—
0
0
(4027681)
44
101
4.42
17.79
1.5
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
135
602
2.31
17.74
2.5
1.8
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
228
1247
1.91
17.47
4.5
3.1
g/l
126.0
128.9
1.02
218
1214
(3024869) Neuronal Ab [Presence] in Serum
25
34
7.42
17.39
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
253
1438
1.85
17.20
3.2
3.2
e9/l
3.8
4.1
1.41
192
1117
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
565
3975
1.55
17.02
4.6
3.6
ng/l
290.6
667.7
0.85
442
3174
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
63
193
3.32
16.98
2.8
2.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
313
1904
1.74
16.91
5.8
3.7
mmol/l
2.1
2.0
0.18
266
1531
(3027945) Reticulocytes/100 erythrocytes in Blood
370
2356
1.67
16.88
2.7
2.6
%
1.8
1.8
0.29
329
2097
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
966
7585
1.45
16.85
5.2
3.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
313
1912
1.73
16.65
5.9
3.7
kpa
5.9
5.9
0.06
304
1852
(3023520) Reticulocytes [#/volume] in Blood
295
1777
1.75
16.48
2.7
2.6
e9/l
69.3
70.3
0.20
238
1349
(3041096) Erythrocytes [Presence] in Urine by Automated
712
5302
1.48
16.23
4.9
3.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
46
118
3.95
16.11
1.6
2.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2344
22082
2.06
16.10
27.3
16.7
umol/l
81.5
78.6
2.28
2344
22075
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
482
3317
1.56
15.91
3.8
2.9
e6/l
2.0
2.1
0.12
309
1803
(40767503) Oxygen content in Capillary blood by calculation
108
459
2.41
15.84
2.7
2.6
%
15.7
16.1
0.44
59
240
(3000475) Leukocytes [#/volume] in Synovial fluid
115
505
2.34
15.67
1.7
1.7
e6/l
13414.7
12832.1
0.05
88
362
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
356
2288
1.65
15.60
2.0
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
121
547
2.27
15.42
2.5
3.3
mmol/l
24.9
25.0
0.13
112
483
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
356
2298
1.64
15.32
2.0
1.7
—
—
—
0
0
(3010421) pH of Blood
124
568
2.25
15.31
4.5
4.7
ph
7.4
7.4
0.17
105
474
(1616796) Gas panel - Central venous blood
109
474
2.36
15.20
4.0
4.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
184
981
1.95
15.19
4.4
3.3
mmol/l
25.6
25.4
0.29
178
950
(40761536) Microorganisms panel - Urine sediment
282
1721
1.72
15.00
6.2
3.9
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
102
434
2.41
14.93
2.0
2.9
umol/l
29.4
37.1
3.61
89
370
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
502
3532
1.53
14.88
3.5
2.7
e6/l
1.1
1.0
0.22
328
2012
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
55
169
3.31
14.79
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
109
480
2.33
14.77
4.7
5.1
mmol/l
2.5
2.6
0.15
81
336
(3028026) IgM [Mass/volume] in Serum or Plasma
213
1210
1.83
14.46
2.6
1.8
g/l
1.7
1.4
0.32
188
1100
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
195
1081
1.87
14.31
2.6
2.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
34
76
4.52
14.24
1.6
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
123
582
2.17
14.05
1.3
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
274
1692
1.70
13.93
5.6
4.0
mmol/l
1.2
1.2
0.66
236
1464
(36660697) Celiac disease serology panel - Serum
242
1444
1.75
13.92
1.2
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
257
1560
1.72
13.91
4.8
2.9
kpa
4.8
4.6
1.02
245
1507
(3000570) Elastase.pancreatic [Mass/mass] in Stool
127
611
2.14
13.91
1.7
1.4
ug/g
259.8
281.1
0.52
74
363
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
42
113
3.76
13.80
1.2
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
87
358
2.48
13.71
1.4
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2334
22093
1.91
13.70
14.5
10.6
u/l
27.1
26.8
0.26
2250
21304
(3015171) Extractable nuclear Ab [Units/volume] in Serum
144
733
2.02
13.57
1.3
1.2
u/ml
1.7
1.0
—
10
64
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
42
115
3.70
13.46
1.2
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
312
2010
1.63
13.45
2.4
2.2
g/l
0.2
0.2
1.16
292
1882
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
207
1192
1.80
13.44
1.5
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2176
20253
1.59
13.05
5.6
4.6
mmol/l
6.2
6.0
10.42
1966
18431
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
120
581
2.12
12.94
1.4
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
100
450
2.27
12.92
3.9
3.1
mmol/l
1.6
1.5
0.49
95
433
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
352
2356
1.58
12.92
2.6
2.7
umol/l
8.9
8.2
0.11
293
2077
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
159
853
1.92
12.90
2.3
1.9
u/l
40.3
38.8
0.45
138
753
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
172
949
1.87
12.81
1.8
1.8
g/l
1.6
1.5
0.64
146
822
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
124
611
2.08
12.78
1.6
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
116
560
2.12
12.61
1.5
1.5
g/l
0.2
0.2
0.37
106
532
(3029937) Albumin [Presence] in Urine by Test strip
690
5310
1.41
12.61
5.3
3.9
estimate
0.0
0.0
0.04
257
1774
(3004616) Nuclear Ab [Presence] in Serum
66
249
2.70
12.43
1.5
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
381
2626
1.53
12.23
7.3
7.3
mmol/l
103.9
104.3
0.92
366
2567
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
66
252
2.66
12.15
2.0
2.3
mg/l
29.1
20.4
0.29
14
61
(3045414) Leukocytes [Presence] in Urine
165
915
1.86
12.10
1.7
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
271
1733
1.63
11.99
9.7
8.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
109
524
2.13
11.99
5.5
4.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
385
2676
1.52
11.86
1.8
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
117
583
2.06
11.72
1.5
1.5
g/l
1.2
1.2
0.01
110
554
(3014111) Lactate [Moles/volume] in Serum or Plasma
282
1836
1.60
11.59
7.3
7.3
mmol/l
1.4
1.4
0.04
270
1773
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
107
518
2.11
11.57
1.3
1.2
u/ml
1.3
3.8
—
8
52
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
108
525
2.11
11.55
1.3
1.2
u/ml
1.8
6.6
—
10
89
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
41
124
3.35
11.36
1.8
2.4
e6/l
521.1
572.1
0.19
35
111
(40760888) Immunoglobulin light chains.free panel - Serum
105
510
2.11
11.26
3.4
3.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
62
239
2.63
11.23
2.9
2.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
273
1780
1.60
11.14
2.4
2.3
ug/l
8.2
7.5
0.16
228
1581
(3037756) Immunofixation for Serum or Plasma
94
440
2.18
11.08
1.6
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
163
927
1.81
11.03
4.0
2.6
%
0.7
0.7
0.08
157
886
(3000330) Specific gravity of Urine by Test strip
177
1032
1.77
11.02
4.6
3.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2112
19714
1.47
10.55
20.6
13.4
ml/min/173m2
79.6
79.8
0.11
1862
16309
(3006653) Thiamine [Moles/volume] in Blood
35
101
3.50
10.44
1.3
1.3
nmol/l
126.8
142.8
1.03
35
101
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
39
121
3.26
10.41
1.8
2.4
e9/l
0.2
0.2
0.39
34
111
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
825
1.82
10.11
2.5
2.4
g/l
7.3
7.4
0.31
100
634
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
825
1.82
10.11
2.5
2.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
85
397
2.18
10.10
2.5
2.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
250
1637
1.59
10.01
4.0
3.9
%
0.8
0.6
0.45
73
379
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
130
713
1.87
9.90
2.9
2.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
96
474
2.07
9.90
2.6
3.0
kpa
8.0
8.0
0.00
90
437
(3037121) Protein [Mass/volume] in Urine
132
728
1.86
9.88
3.5
3.4
g/l
0.6
0.3
1.45
59
313
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
145
825
1.80
9.82
2.6
2.4
g/l
3.7
3.8
0.32
95
600
(3017181) Myelocytes/100 leukocytes in Blood
268
1794
1.55
9.74
4.2
4.1
%
1.2
0.9
0.53
89
522
(3021440) Promyelocytes/100 leukocytes in Blood
258
1713
1.56
9.72
4.2
4.2
%
0.1
0.1
0.07
87
486
(3024731) MCV [Entitic volume]
2377
22891
1.85
9.41
35.1
20.9
fl
91.5
91.2
1.57
2351
22545
(3035941) MCH [Entitic mass]
2377
22893
1.85
9.38
35.0
20.9
pg
30.4
30.4
0.33
2352
22547
(3026361) Erythrocytes [#/volume] in Blood
2377
22895
1.85
9.34
35.2
21.0
e12/l
4.4
4.5
18.39
2337
22220
(3010813) Leukocytes [#/volume] in Blood
2377
22899
1.85
9.28
35.2
21.0
e9/l
7.1
6.7
9.25
2337
22225
(3007461) Platelets [#/volume] in Blood
2376
22887
1.84
9.27
35.2
21.0
e9/l
254.2
248.3
4.22
2342
22281
(3000963) Hemoglobin [Mass/volume] in Blood
2377
22901
1.84
9.25
35.4
21.1
g/l
132.9
136.1
19.54
2351
22556
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
96
488
2.01
9.17
1.5
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
93
468
2.03
9.13
2.5
2.2
g/l
124.6
129.8
1.14
73
338
(3005322) IgE [Units/volume] in Serum or Plasma
191
1202
1.64
9.00
1.4
1.3
u/ml
278.2
204.6
0.35
172
1108
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
55
4.21
8.91
1.1
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
119
658
1.85
8.86
3.3
3.6
ratio
3.4
2.8
—
6
46
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
332
2373
1.46
8.79
1.8
1.8
%
1.7
1.5
3.15
276
2085
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
36
119
3.05
8.70
1.3
1.6
u/l
5.2
8.5
1.34
29
101
(3011985) Renin [Units/volume] in Plasma
59
252
2.37
8.70
1.4
1.4
mu/l
76.8
56.3
0.47
49
225
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
133
769
1.77
8.57
2.4
2.4
g/l
9.1
10.4
4.71
107
664
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
27
75
3.63
8.56
1.3
1.1
ng/l
358.2
626.1
—
5
22
(3004809) Band form neutrophils/100 leukocytes in Blood
75
357
2.14
8.55
4.0
3.6
%
1.5
1.5
0.03
60
275
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
133
771
1.77
8.49
2.6
2.4
g/l
2.8
3.1
2.62
96
616
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
30
90
3.36
8.48
2.6
2.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
290
2033
1.48
8.46
1.8
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
120
676
1.81
8.43
3.5
3.6
mg/l
43.9
65.9
0.96
87
544
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
33
5.18
8.40
1.5
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
34
111
3.09
8.40
1.4
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
120
677
1.81
8.39
3.5
3.6
mg/l
26.6
81.3
1.87
88
547
(3025159) Blasts/100 leukocytes in Blood
238
1605
1.53
8.36
4.3
4.2
%
0.0
0.5
1.04
75
406
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
101
3.20
8.36
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2181
20665
1.45
8.33
5.4
4.5
mmol/l
4.5
4.7
10.20
1989
19091
(3008757) Leukocyte morphology finding [Identifier] in Blood
54
227
2.41
8.26
5.4
4.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
182
1159
1.62
8.19
2.9
3.3
pmol/l
4.3
4.5
1.81
154
1025
(3022217) INR in Platelet poor plasma by Coagulation assay
362
2675
1.41
7.97
22.8
24.6
inr
1.2
1.3
1.80
53
364
(3017704) Immunofixation for Urine
37
131
2.85
7.96
1.3
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2164
20519
1.42
7.81
5.4
4.4
mmol/l
1.4
1.5
7.66
1965
18840
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2103
19847
1.38
7.78
4.8
4.0
mmol/l
1.4
1.3
5.53
1901
18098
(3011412) CD3 cells [#/volume] in Blood
46
185
2.51
7.75
2.0
2.2
e9/l
1.2
1.1
0.17
20
113
(3051593) INR in Capillary blood by Coagulation assay
25
71
3.55
7.69
20.0
18.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
30
96
3.15
7.68
1.3
1.0
u/l
1.0
1.1
0.67
13
49
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
27
81
3.36
7.66
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2210
21053
1.44
7.59
5.9
5.0
mmol/l
2.6
2.8
13.63
2006
19336
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
79
403
1.99
7.53
1.2
1.2
u/ml
52.3
47.7
—
6
41
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
29
5.20
7.45
5.3
4.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
69
339
2.06
7.30
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
29
94
3.11
7.28
1.1
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
29
94
3.11
7.28
1.1
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
43
173
2.51
7.26
1.3
1.1
—
45.0
—
0
7
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
79
3.32
7.24
1.1
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
247
1734
1.47
7.15
3.8
2.7
ng/l
148.4
200.0
1.82
235
1582
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
106
2.95
7.12
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
51
224
2.30
7.12
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
170
1103
1.58
7.10
1.3
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
44
181
2.46
7.10
2.1
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
534
4272
1.32
7.03
4.5
3.9
kg/l
1.0
1.0
0.42
108
609
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
15
31
4.86
6.93
1.3
1.5
ng/l
83.4
130.4
1.11
15
31
(3010144) Erythrocytes [#/volume] in Synovial fluid
47
202
2.35
6.90
1.4
1.4
e6/l
26639.6
59567.9
0.46
31
144
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
57
266
2.17
6.90
1.7
1.5
%
53.2
58.2
0.38
38
165
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
31
109
2.87
6.79
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
22
63
3.51
6.71
6.0
5.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
48
211
2.30
6.71
3.8
3.5
%
62.1
56.1
0.94
36
132
(40768804) Tissue Pathology biopsy report
974
8442
1.25
6.70
2.2
2.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
50
225
2.25
6.62
3.3
6.3
mmol/l
6.9
7.4
0.69
39
192
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
37
145
2.58
6.61
1.5
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
73
380
1.95
6.61
1.6
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
53
245
2.19
6.58
1.3
1.4
pmol/l
317.3
287.3
0.25
36
191
(4010399)
216
1503
1.48
6.54
1.4
1.4
—
—
—
0
0
(3036489) Thrombin time
115
692
1.69
6.50
2.7
1.9
s
21.1
21.8
0.66
102
611
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
27
90
3.02
6.50
1.7
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
27
90
3.02
6.50
1.7
1.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
42
177
2.40
6.46
2.5
2.2
ml
595.7
645.6
0.28
27
113
(4015189)
21
60
3.52
6.43
4.4
2.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
117
711
1.68
6.38
2.6
2.4
g/l
0.6
1.3
1.40
97
624
(3009214) Lutropin [Units/volume] in Serum or Plasma
78
421
1.88
6.36
1.6
1.3
u/l
12.6
9.4
1.02
63
335
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
92
523
1.79
6.35
2.1
2.0
mg/l
10.8
11.9
0.46
85
482
(21494755) Public health laboratory ask at order entry panel
105
1710
0.60
6.30
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
665
5544
1.27
6.29
1.4
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
21
61
3.46
6.28
2.0
2.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
66
338
1.98
6.28
1.3
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
27
92
2.96
6.27
1.7
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
316
2374
1.38
6.27
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
547
4453
1.29
6.25
4.9
4.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
29
104
2.81
6.16
3.5
2.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1328
11978
1.23
6.15
2.9
2.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
186
1273
1.50
6.12
3.3
2.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
112
681
1.68
6.11
4.0
2.8
u/ml
0.3
0.3
0.21
61
385
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
95
552
1.75
6.10
4.0
3.1
mg/l
1.7
1.6
0.60
85
505
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
119
738
1.64
6.02
1.1
1.1
u/ml
—
1.4
—
0
12
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
31
4.54
5.98
8.9
12.2
mmol/l
4.5
5.7
1.16
14
31
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
94
548
1.74
5.98
2.6
2.3
ug/min
183.4
112.3
0.38
55
334
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
54
263
2.08
5.91
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
917
7978
1.24
5.89
4.7
4.9
ug/l
2.2
2.8
1.48
829
7158
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
38
160
2.40
5.88
1.3
1.1
—
4.7
—
0
7
(3006270) Folate [Moles/volume] in Blood
38
160
2.40
5.88
1.2
1.2
nmol/l
301.2
375.9
1.28
27
139
(40761539) Cells [Type] in Urine sediment by Light microscopy
19
54
3.54
5.88
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1035
9123
1.23
5.87
14.8
9.7
e9/l
0.0
0.0
0.43
911
7438
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
77
426
1.83
5.84
5.9
5.1
iu/ml
523.5
694.6
0.19
18
60
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
49
231
2.14
5.83
1.6
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
30
113
2.68
5.83
1.6
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
30
113
2.68
5.83
1.6
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
30
113
2.68
5.83
1.6
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
30
113
2.68
5.83
1.6
1.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
82
463
1.80
5.82
4.6
1.9
nmol/l
0.9
0.8
0.27
68
379
(3035637) Corticotropin [Mass/volume] in Plasma
48
225
2.16
5.80
1.4
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
23
75
3.09
5.77
2.4
1.6
umol/l
89.5
101.9
0.13
13
49
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
79
443
1.81
5.74
1.3
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
68
364
1.89
5.72
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
79
444
1.80
5.70
5.1
2.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
149
989
1.54
5.68
7.0
4.0
mmol/l
24.3
24.1
0.28
131
883
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
175
1202
1.49
5.68
1.2
1.2
iu/ml
118.8
158.9
0.77
60
446
(3024980) IgG subclass 4 [Mass/volume] in Serum
61
317
1.95
5.60
1.3
1.7
g/l
0.4
0.9
3.91
43
248
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
300
2277
1.36
5.58
1.8
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
45
209
2.17
5.57
1.4
1.2
u/l
57.9
57.4
0.02
30
147
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
340
2637
1.34
5.48
7.1
6.6
—
—
—
0
0
(3020891) Body temperature
126
812
1.58
5.48
5.2
4.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
88
517
1.73
5.47
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
70
386
1.84
5.39
1.6
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
34
142
2.41
5.38
1.7
2.2
e6/l
816.4
610.3
0.70
20
61
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
671
5688
1.25
5.38
1.8
1.6
mmol/l
1.5
1.4
1.50
555
4740
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
17
48
3.56
5.32
1.6
1.5
ug/l
0.6
0.4
0.61
11
31
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
22
5.02
5.26
2.1
2.9
u/field
0.8
0.5
0.35
11
22
(3003181) Sodium [Moles/volume] in Urine
64
347
1.87
5.21
1.4
1.4
mmol/l
59.7
60.2
0.03
48
276
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
49
243
2.04
5.15
1.2
1.3
nmol/l
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
99
611
1.65
5.15
4.1
3.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
45
217
2.09
5.10
1.6
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
40
3.77
5.09
1.2
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
27
104
2.61
5.06
1.8
1.6
u/field
2.0
2.1
0.03
22
79
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
134
2.41
5.05
1.9
1.6
u/l
10.1
6.5
0.52
17
67
(4146454)
50
252
2.00
5.04
2.6
2.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
85
507
1.70
5.04
1.6
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
128
845
1.54
5.03
2.4
2.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
103
647
1.62
5.01
2.3
2.2
g/l
38.4
37.7
0.76
86
563
(40761535) Cells panel - Urine sediment
232
1720
1.38
5.00
3.8
3.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
135
2.39
4.98
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
87
524
1.68
4.98
1.6
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
100
627
1.62
4.90
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
57
305
1.89
4.85
2.3
2.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
34
150
2.28
4.80
1.3
1.4
promille
1.3
1.3
0.01
26
116
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
23
84
2.75
4.77
1.2
1.4
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
18
58
3.12
4.63
1.8
1.5
pmol/l
14.0
15.9
0.44
12
49
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
94
591
1.61
4.58
3.0
2.0
%
96.2
90.1
1.73
88
557
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
462
3817
1.26
4.57
2.9
3.1
mmol/l
2.4
2.5
0.14
401
3363
(3044889) 12 lead EKG panel
1596
14893
1.20
4.47
4.6
3.8
—
—
—
0
0
(4062490)
39
188
2.09
4.46
1.4
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
118
1727
0.67
4.44
1.6
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
12
30
4.01
4.43
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
50
265
1.90
4.41
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
164
1173
1.43
4.37
1.9
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1960
18672
1.23
4.37
24.1
15.2
%
38.5
39.9
5.69
1168
13226
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
26
4.25
4.35
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
60
339
1.79
4.34
1.3
1.2
u/ml
289.7
268.4
0.20
44
202
(3021879) Hepatitis B virus core Ab [Presence] in Serum
181
1320
1.40
4.32
1.5
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
89
561
1.61
4.31
3.8
2.4
g/l
3.7
3.6
0.22
84
532
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
60
340
1.78
4.30
1.1
1.1
iu/ml
19.9
90.3
1.17
14
73
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
49
261
1.90
4.27
1.3
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
31
3.88
4.25
1.2
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
38
186
2.06
4.20
1.4
1.5
g/l
0.4
0.4
0.36
24
132
(3027135) IgG subclass 1 [Mass/volume] in Serum
38
186
2.06
4.20
1.4
1.5
g/l
5.5
6.8
1.54
25
133
(3028192) IgG subclass 2 [Mass/volume] in Serum
38
186
2.06
4.20
1.4
1.5
g/l
2.5
2.9
1.02
24
133
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
70
419
1.69
4.15
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
70
419
1.69
4.15
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
187
2.05
4.14
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
49
264
1.87
4.13
1.3
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
29
128
2.28
4.13
1.2
1.4
—
545.5
—
0
11
(40758558) Short blood count panel - Blood
611
5255
1.22
4.12
7.4
6.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
60
346
1.75
4.07
1.4
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
96
626
1.55
4.05
2.4
2.3
g/l
0.0
0.0
1.10
87
577
(3025468) Yersinia sp identified in Specimen by Organism specific culture
48
259
1.87
4.04
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
48
259
1.87
4.04
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
38
189
2.03
4.03
1.8
2.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
252
1959
1.32
4.01
3.5
2.4
u/l
32.8
64.1
0.70
216
1690
(3003327) Ova and parasites identified in Stool by Light microscopy
94
612
1.56
4.00
1.6
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
28
3.94
3.97
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
18
64
2.83
3.95
2.7
3.0
umol/l
26.6
28.8
0.39
13
47
(3005988) Vibrio sp identified in Specimen by Organism specific culture
48
261
1.86
3.95
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
108
728
1.51
3.93
1.5
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
62
366
1.71
3.89
3.8
3.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
130
912
1.45
3.88
1.3
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
16
54
2.98
3.85
1.6
2.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
53
300
1.78
3.85
2.4
1.9
u/l
73.4
1845.1
—
8
107
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
41
215
1.92
3.77
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
81
517
1.59
3.77
1.5
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
353
2889
1.26
3.77
1.4
1.4
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
6
5
12.02
3.76
1.3
1.2
nmol/l
564.0
569.7
—
6
5
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
175
1304
1.37
3.71
2.0
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
79
505
1.58
3.66
1.2
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
16
5.64
3.65
1.7
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
13
40
3.26
3.62
1.0
1.2
umol/24h
0.6
0.7
—
6
24
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
74
1136
0.64
3.55
1.4
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
83
541
1.55
3.55
3.9
2.3
%
209.3
190.2
1.04
77
511
(3032057) Clostridioides difficile [Presence] in Stool
14
46
3.06
3.53
1.9
2.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
57
2.82
3.52
1.3
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
63
385
1.65
3.51
1.7
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
41
3.18
3.49
1.5
2.4
e6/l
90.0
150.0
—
5
17
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
79
514
1.55
3.42
1.4
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
39
209
1.88
3.40
1.2
1.3
mosm/kgh2o
283.5
277.0
0.87
31
157
(3028433) Virus identified in Specimen by Culture
18
70
2.58
3.38
1.1
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
57
343
1.68
3.38
1.7
1.4
u/ml
124.1
123.7
0.01
14
62
(3026389) Candida sp identified in Specimen by Organism specific culture
44
246
1.80
3.36
1.5
1.3
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
10
7.01
3.36
1.3
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
279
2252
1.27
3.35
3.0
4.3
ug/l
113.6
23.8
0.44
238
1849
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
8
14
5.73
3.34
1.0
1.0
—
22.2
—
0
5
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
29
141
2.07
3.32
1.1
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
20
83
2.42
3.30
1.9
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
19
77
2.48
3.29
1.1
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
88
594
1.50
3.23
2.4
2.3
g/l
0.0
0.0
0.00
80
546
(3025315) Body weight
9
19
4.75
3.23
6.3
4.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
10
28
3.58
3.19
1.7
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
91
621
1.48
3.18
1.6
1.6
iu/ml
1.3
11.1
0.49
23
122
(3011397) Hemoglobin [Presence] in Urine by Test strip
532
4620
1.19
3.16
4.2
3.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
25
117
2.15
3.16
1.3
1.4
nmol/l
1.1
1.2
0.20
19
91
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
51
304
1.69
3.15
1.6
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
50
297
1.70
3.13
1.5
1.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
28
138
2.04
3.11
1.7
2.0
mmol/l
6.8
7.0
0.11
17
84
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
62
2.59
3.04
1.3
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
62
2.59
3.04
1.3
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
86
587
1.48
3.02
2.4
2.3
g/l
0.0
0.0
0.00
80
545
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
81
2.36
2.98
2.3
2.8
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
5
10.02
2.98
1.2
1.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
11
35
3.15
2.93
1.5
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
21
95
2.22
2.89
1.8
2.6
u/ml
1096.0
1280.6
0.17
21
95
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
58
2.60
2.87
1.3
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
27
137
1.98
2.80
2.5
2.1
min
527.3
491.1
0.73
18
97
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
23
3.92
2.77
1.8
2.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
23
3.92
2.77
1.2
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
23
3.92
2.77
1.8
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
69
460
1.51
2.74
2.1
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
14
5.01
2.73
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
33
182
1.82
2.69
1.5
1.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
24
3.76
2.67
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
26
133
1.96
2.65
2.0
2.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
16
67
2.40
2.63
1.4
1.2
g/l
42.8
37.9
—
9
35
(3024932) HLA-DR beta [Type]
16
67
2.40
2.63
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
63
416
1.53
2.62
4.4
3.7
%
60.7
57.9
1.15
63
416
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
141
1.92
2.60
2.1
2.0
%
14.7
13.4
0.28
18
55
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
127
1.98
2.60
1.0
1.0
ng/l
845.5
716.5
0.70
19
86
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
25
3.61
2.57
1.3
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
87
2.19
2.57
1.3
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
25
128
1.96
2.55
1.1
1.0
ng/l
371.5
317.9
0.19
19
90
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
128
1.96
2.55
1.0
1.0
ng/l
37.4
44.5
0.44
19
87
(3011288) Drugs identified in Urine by Screen method
47
292
1.62
2.54
1.6
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
208
1.74
2.54
1.9
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
63
925
0.67
2.52
1.8
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
32
179
1.80
2.51
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
381
1.53
2.49
1.5
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
202
1630
1.26
2.49
2.4
2.2
nmol/l
12.3
13.1
0.77
177
1437
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
35
202
1.74
2.48
1.2
1.5
%
28.8
32.8
0.24
21
124
(3024471) HLA-A [Type]
16
69
2.33
2.48
1.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
21
3.82
2.46
1.3
1.2
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
8
21
3.82
2.46
1.1
1.2
mmol/l
236.8
147.3
—
8
16
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
15
63
2.39
2.46
1.9
2.7
ug/l
1.4
1.2
0.10
15
58
(3022689) Creatine [Moles/volume] in Urine
14
57
2.46
2.45
1.4
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
17
76
2.25
2.44
1.1
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
35
204
1.73
2.41
4.3
3.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
33
190
1.75
2.37
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
33
190
1.75
2.37
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
33
190
1.75
2.37
1.6
1.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
22
3.64
2.36
1.3
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
13
52
2.51
2.36
1.0
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
25
133
1.89
2.31
1.8
2.7
%
36.6
38.5
—
10
45
(3002619) Bacteria identified in Specimen by Culture
10
35
2.86
2.30
1.8
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
168
1340
1.27
2.29
1.2
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
59
2.38
2.29
1.3
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
40
246
1.64
2.28
1.6
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
38
231
1.66
2.27
1.7
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
82
590
1.40
2.26
1.3
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
23
120
1.93
2.25
1.5
1.2
u/l
17.2
21.6
0.37
18
103
(3039443) Prostate specific Ag panel - Serum or Plasma
30
505
0.59
2.23
1.7
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
29
164
1.78
2.23
2.0
2.2
u/field
3.4
1.9
0.48
19
68
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
16
73
2.20
2.21
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
51
336
1.53
2.20
1.5
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
13
54
2.41
2.19
1.3
1.1
pmol/l
314.5
258.5
—
6
39
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
48
312
1.55
2.19
1.5
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
12
48
2.51
2.18
1.7
1.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
42
2.63
2.18
2.9
2.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
82
595
1.39
2.16
1.3
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
30
3.01
2.14
1.4
2.2
umol/l
17.5
18.5
—
9
30
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
30
3.01
2.14
1.2
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
32
189
1.70
2.13
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
315
1.53
2.11
1.4
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
145
1.80
2.10
1.2
1.3
u/ml
0.2
0.9
0.79
11
71
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
43
2.57
2.09
1.5
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
66
465
1.43
2.06
1.6
1.7
mu/l
290.7
300.5
0.07
61
428
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
103
1.95
2.05
1.1
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
13
56
2.33
2.04
1.2
1.4
%
92.9
87.6
—
7
29
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
51
343
1.50
2.02
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
26
3.08
2.01
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
80
587
1.37
2.00
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
148
1.76
1.98
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
148
1.76
1.98
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
87
648
1.36
1.98
1.7
1.4
iu/l
24.4
32.2
1.65
73
554
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
23
126
1.83
1.98
1.5
1.2
u/l
71.6
85.2
0.51
18
110
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
57
2.29
1.97
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
33
524
0.62
1.97
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
18
91
1.99
1.95
1.2
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
296
0.50
1.95
1.4
1.5
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
11
4.55
1.94
17.4
11.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
30
180
1.67
1.92
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
26
150
1.74
1.90
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
26
150
1.74
1.90
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
26
150
1.74
1.90
1.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
46
308
1.50
1.88
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
51
350
1.47
1.85
1.7
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
64
459
1.40
1.85
2.3
2.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
17
3.54
1.83
1.2
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
12
4.17
1.82
1.4
5.2
—
—
—
0
0
(4035726)
228
1932
1.20
1.82
1.4
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
53
2.27
1.80
1.1
1.1
—
—
—
0
0
(4024509)
33
207
1.60
1.80
1.6
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
23
3.05
1.80
1.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
23
3.05
1.80
1.3
2.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
60
2.17
1.77
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
60
2.17
1.77
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
131
1.76
1.77
1.1
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
25
147
1.71
1.74
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
64
465
1.39
1.73
1.5
1.9
iu/l
2.9
5.0
2.40
19
158
(21494815) CD4 cells/100 lymphocytes in Specimen
27
163
1.66
1.71
2.0
2.0
%
42.6
45.2
—
7
23
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
38
250
1.53
1.71
1.2
1.0
u/ml
3.6
2.6
—
9
107
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
34
218
1.57
1.70
3.1
3.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
11
48
2.30
1.70
1.6
1.3
umol/l
15.5
16.2
0.17
11
43
(40759836) Histone Ab [Presence] in Serum by Immunoblot
25
148
1.70
1.70
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
133
1.74
1.70
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
55
2.19
1.67
1.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
19
3.16
1.66
1.0
1.3
u/l
8.2
16.2
—
6
19
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
30
188
1.60
1.66
2.5
2.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
32
204
1.58
1.65
1.2
1.4
—
28.5
—
0
11
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
25
2.80
1.65
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
66
487
1.36
1.64
1.6
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
30
189
1.59
1.63
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
49
344
1.43
1.62
1.1
1.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
14
3.58
1.61
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
77
584
1.33
1.61
2.2
1.7
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
56
2.15
1.61
1.2
1.1
%
99.7
88.9
—
6
28
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
426
4724
0.88
1.60
2.8
3.1
ug/l
0.7
0.8
1.78
288
3159
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
70
2.01
1.59
1.0
1.0
miu/ml
1383.9
1610.0
0.28
14
70
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
65
483
1.36
1.56
2.5
3.3
u/ml
886.3
901.3
0.01
58
454
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
85
1.89
1.55
1.1
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
20
115
1.75
1.52
1.3
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
15
79
1.90
1.49
4.5
3.6
—
—
—
0
0
(4034850)
86
671
1.29
1.49
12.6
9.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
58
2.07
1.49
1.6
1.3
ug/l
10.1
8.8
0.38
12
58
(3007566) Smooth muscle Ab [Titer] in Serum
74
566
1.32
1.48
1.1
1.2
titre
48.0
98.6
—
5
44
(3025577) Chromium [Mass/volume] in Blood
23
139
1.66
1.48
2.1
2.0
ug/l
1.5
2.1
0.97
15
120
(4211845)
16
87
1.84
1.45
4.3
3.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
22
2.73
1.43
6.3
3.7
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
22
2.73
1.43
1.7
1.5
umol/l
53.2
45.8
—
6
22
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
12
59
2.04
1.43
1.9
2.5
%
212.1
179.6
0.22
12
54
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
39
270
1.45
1.42
1.1
1.1
%
128.0
116.8
1.15
32
248
(44816559) Phosphatidylethanol [Mass/volume] in Blood
46
329
1.41
1.41
1.3
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
46
2.18
1.40
2.4
2.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
53
2.08
1.38
6.2
6.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
41
2.20
1.37
1.1
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
23
2.61
1.36
1.2
2.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
17
2.94
1.36
1.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
17
2.94
1.36
1.0
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
15
82
1.83
1.35
1.5
1.1
iu/ml
350.7
209.6
0.34
15
82
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
42
2.15
1.33
1.3
3.6
—
—
—
0
0
(4198724)
11
54
2.04
1.32
1.4
1.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
29
192
1.52
1.32
1.3
1.5
nmol/l
0.3
0.3
0.08
22
145
(3045716) Anion gap in Serum or Plasma
17
98
1.74
1.31
1.7
2.8
mmol/l
9.7
9.7
—
7
76
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
43
2.10
1.30
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1673
17209
0.92
1.30
28.8
18.3
g/l
331.9
332.5
1.68
1664
17079
(3016879) Cocaine [Presence] in Urine
56
421
1.34
1.29
1.6
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
18
106
1.70
1.29
1.4
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
60
456
1.32
1.29
5.7
3.4
mg/l
29.0
26.2
0.17
30
286
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
175
0.51
1.28
1.6
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
192
0.52
1.27
1.4
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
20
122
1.64
1.27
3.0
3.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
99
1.72
1.27
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
35
2.29
1.27
1.0
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
21
130
1.62
1.26
1.1
1.3
mmol/l
14.4
12.3
—
8
42
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
25
2.40
1.24
1.0
1.2
umol/24h
1.8
1.9
—
6
25
(3009466) Valproate [Moles/volume] in Serum or Plasma
38
270
1.41
1.23
4.2
5.6
umol/l
338.3
367.4
0.56
30
242
(3005570) Glucose [Moles/volume] in Urine
30
204
1.48
1.22
2.1
2.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
5
19
2.63
1.21
1.4
1.2
ug/l
76.0
133.2
—
5
9
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
142
0.49
1.20
1.4
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
19
117
1.63
1.18
1.4
1.8
umol/l
7.8
12.4
0.34
14
72
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
240
2125
1.14
1.18
1.5
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
14
79
1.78
1.17
1.9
2.2
%
156.0
165.9
0.15
14
74
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
27
182
1.49
1.15
1.3
1.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
39
2.05
1.15
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
58
448
1.30
1.14
1.7
1.9
—
—
—
0
0
(44813793)
19
119
1.60
1.11
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
137
0.51
1.09
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
137
0.51
1.09
1.4
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
21
2.38
1.09
2.0
2.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
162
0.55
1.08
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
162
0.55
1.08
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
162
0.55
1.08
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
162
0.55
1.08
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
118
996
1.19
1.07
1.5
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
29
203
1.43
1.05
3.5
3.1
mg/l
17.1
31.8
0.77
20
154
(3036071) Salmonella sp Ab [Titer] in Serum
12
67
1.79
1.04
1.5
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
154
1.50
1.03
1.7
1.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
22
2.28
1.03
1.4
2.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
22
2.28
1.03
1.0
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
22
2.28
1.03
1.0
1.5
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
22
2.28
1.03
1.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
22
2.28
1.03
9.4
13.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
20
130
1.54
1.02
1.4
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
108
0.46
1.00
15.0
13.4
nmol/l
1166.2
849.4
—
5
102
(3023383) Lactate [Moles/volume] in Pleural fluid
12
68
1.77
1.00
1.2
1.5
mmol/l
3.2
3.5
0.11
12
61
(3027008) Opiates [Presence] in Urine
57
449
1.28
0.99
1.6
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
37
274
1.36
0.99
3.3
2.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
49
1.84
0.98
6.6
7.0
—
—
—
0
0
(44806420)
11
61
1.81
0.98
3.0
2.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
36
1.95
0.97
7.9
7.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
211
0.61
0.96
1.8
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
57
452
1.27
0.95
1.7
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
133
1.51
0.94
1.2
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
62
1.78
0.94
2.1
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
62
1.78
0.94
2.1
2.9
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
37
1.89
0.94
1.0
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
37
1.89
0.94
1.4
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
117
1.54
0.93
2.2
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
159
1.45
0.91
1.0
1.2
—
—
—
0
0
(4094501)
73
601
1.22
0.89
1.2
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
28
204
1.38
0.85
1.4
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
26
355
0.73
0.84
3.1
3.8
u/ml
30.2
35.2
0.15
26
344
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
45
1.78
0.84
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
110
949
1.17
0.83
1.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
46
1.74
0.82
1.6
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
55
444
1.24
0.82
1.6
1.8
—
—
—
0
0
(4281824)
14
213
0.66
0.81
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
26
189
1.38
0.81
2.0
1.8
—
—
—
0
0
(4306422)
36
276
1.31
0.80
1.3
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
278
1.30
0.77
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
59
1.70
0.75
1.3
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
280
1.29
0.74
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
16
108
1.48
0.73
1.6
2.4
—
—
—
0
0
(4133840)
9
55
1.64
0.73
1.7
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
55
1.64
0.73
1.1
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
100
1.50
0.72
1.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
39
1.80
0.72
1.0
1.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
57
1.58
0.71
1.7
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
26
1.92
0.70
1.2
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
41
1.71
0.70
3.7
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
69
1.60
0.68
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
118
0.59
0.67
2.1
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
102
1.47
0.67
3.8
4.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
11
168
0.65
0.67
1.3
1.0
—
0.4
—
0
40
(3005011) Chlamydia sp Ab [Titer] in Serum
5
28
1.79
0.66
1.8
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
49
403
1.22
0.65
3.1
3.2
nmol/l
0.8
0.8
0.52
39
312
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
39
313
1.25
0.65
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
120
1.42
0.64
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
120
1.42
0.64
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
47
386
1.22
0.64
1.8
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
49
1.63
0.62
1.4
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
707
7348
0.95
0.60
3.7
2.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
54
1.48
0.57
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
21
158
1.33
0.57
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
98
1.43
0.56
1.4
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
39
1.54
0.53
1.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
134
1.35
0.53
1.9
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
134
1.35
0.53
1.9
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
126
1.35
0.51
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
64
1.41
0.51
1.3
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
106
953
1.12
0.50
2.9
3.7
u/ml
54.6
67.0
0.28
101
923
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
288
1.22
0.50
1.4
1.2
u/ml
2.5
4.5
1.06
13
124
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
663
6397
1.05
0.49
4.1
4.2
%
21.6
21.5
0.09
300
3122
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
119
1.35
0.48
1.4
1.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
77
1.43
0.45
2.0
2.4
—
—
—
0
0
(1002224) Polysomnography panel
93
837
1.12
0.45
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
50
1.40
0.45
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
175
1.26
0.43
1.3
1.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
8
56
1.43
0.42
1.6
1.4
%
36.6
27.9
—
8
43
(40758292) HTLV I+II Ab panel - Serum
5
32
1.56
0.42
2.0
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
33
1.52
0.41
1.6
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
7.5
—
—
—
0
0
(4268621)
25
204
1.23
0.40
2.6
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
186
1742
1.07
0.40
2.6
2.7
ml/min/173m2
65.1
65.1
0.00
71
681
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
18
0.00
0.40
0.0
6.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
18
0.00
0.40
0.0
3.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
106
1.32
0.39
1.0
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
28
233
1.20
0.38
1.5
1.4
e6/l
236373.9
100664.1
0.54
15
141
(3038177) Helicobacter pylori Ab [Presence] in Serum
35
300
1.17
0.36
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
291
1.17
0.35
1.4
1.2
u/ml
10.2
4.4
—
9
97
(3047007) Chlamydophila sp Ab [Presence] in Serum
32
273
1.17
0.35
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
256
2681
0.95
0.32
1.5
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
101
1.29
0.31
1.3
2.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
54
1.30
0.30
1.1
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
157
1.21
0.29
1.4
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
56
1.25
0.29
1.1
1.0
—
—
—
0
0
(3000492) Spirometry study
210
2004
1.05
0.28
1.4
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
63
1.27
0.27
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
233
1.16
0.27
1.4
1.3
mmol/l
7.2
7.4
0.14
20
171
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
310
1.13
0.26
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
289
2793
1.04
0.24
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
265
0.87
0.24
1.1
1.1
u/ml
0.3
1.8
—
7
109
(3035320) C reactive protein [Mass/volume] in Body fluid
15
124
1.21
0.24
2.3
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
180
1.17
0.23
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
12
147
0.82
0.23
1.1
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
106
1.23
0.23
1.4
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
106
1.23
0.23
1.4
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
54
588
0.92
0.23
1.3
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
24
274
0.87
0.22
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
29
257
1.13
0.22
1.8
1.3
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
1.3
—
0
10
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
10
0.00
0.21
0.0
1.1
—
7.7
—
0
10
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.1
—
21.6
—
0
13
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.1
—
8.1
—
0
13
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.1
—
38.4
—
0
13
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
272
0.88
0.20
1.1
1.1
u/ml
1.1
4.9
—
10
130
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
113
0.80
0.20
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
14
118
1.19
0.19
1.8
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
52
1.15
0.19
2.0
1.6
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
7
60
1.17
0.17
1.7
1.9
mg/l
6.7
9.1
—
7
48
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
52
484
1.08
0.17
1.3
1.2
miu/ml
168.8
202.3
0.35
19
206
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
70
0.71
0.16
1.6
2.3
nmol/l
162.8
151.5
—
5
62
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
68
1.18
0.16
2.6
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
56
597
0.94
0.16
1.7
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
172
0.87
0.15
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
143
1481
0.96
0.15
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
83
1.08
0.14
2.7
1.7
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
7
87
0.80
0.14
1.0
1.1
—
0.4
—
0
20
(3002523) Influenza virus A Ag [Presence] in Specimen
25
275
0.91
0.14
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
84
802
1.05
0.14
2.4
3.5
u/ml
51.4
1952.6
0.89
63
684
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
59
558
1.06
0.13
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
25
273
0.91
0.13
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
230
0.91
0.11
2.0
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
41
387
1.06
0.10
1.2
1.2
u/l
57.8
42.7
0.29
36
328
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
106
1.13
0.09
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
57
546
1.04
0.09
1.4
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
65
1.08
0.08
1.0
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
67
1.04
0.08
1.6
2.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
101
0.89
0.06
1.1
1.2
—
—
—
0
0
(44790047)
25
237
1.06
0.05
1.6
1.5
—
—
—
0
0
(44790048)
25
237
1.06
0.05
1.6
1.5
—
—
—
0
0
(44790049)
25
237
1.06
0.05
1.6
1.5
—
—
—
0
0
(44806118)
25
237
1.06
0.05
1.6
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
70
718
0.97
0.05
1.5
1.7
mg/l
4.0
4.0
0.00
54
517
(3036782) Glucose [Moles/volume] in Pleural fluid
19
202
0.94
0.05
1.9
1.5
mmol/l
6.5
6.5
0.03
19
187
(3002385) Erythrocyte distribution width [Ratio]
1701
16973
1.01
0.05
28.7
17.4
%
13.9
13.7
4.62
1681
16565
(3004716) Salmonella sp identified in Stool by Organism specific culture
96
943
1.02
0.04
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
32
309
1.04
0.03
1.2
1.1
u/ml
0.3
1.8
—
7
128
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
142
1.06
0.02
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
51
501
1.02
0.02
1.3
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
133
1.05
0.01
1.4
1.3
—
1.5
—
0
8
(40768793) Breast Pathology biopsy report
46
452
1.02
0.01
1.3
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
154
1.04
0.00
1.4
1.5
g/l
0.9
1.0
0.35
16
154
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
204
1.03
0.00
1.1
1.0
u/ml
2.0
2.6
—
9
73
(40768795) Lymph node Pathology biopsy report
21
204
1.03
0.00
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
105
0.95
0.00
4.4
3.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
125
0.96
0.00
3.3
6.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
121
0.99
0.00
1.3
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
191
0.99
0.00
1.1
1.1
u/ml
12.7
3.7
—
6
67
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
23
229
1.00
0.00
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
233
0.99
0.00
1.9
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
15
147
1.02
0.00
1.7
1.3
u/l
14.7
12.2
0.29
15
135
(40765096) Chromosome analysis panel by Banding
7
75
0.93
0.00
1.3
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
7.6
—
0
8
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
2.5
—
2.7
—
0
8
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
61
0.98
0.00
1.3
2.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
9
91
0.99
0.00
18.0
12.0
mmol/l
0.7
0.6
—
9
85
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
94
0.96
0.00
1.4
1.4
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
129.3
—
0
6
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
58
0.86
0.00
1.8
3.2
mg/l
4.1
7.2
—
5
46
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
65
0.92
0.00
1.2
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
174.4
—
0
5
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
235.5
—
0
6
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.4
—
1.1
—
0
5
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
2.0
—
855.8
—
0
5

Mortality – FinRegistry

Association

Association between endpoint G6_NEUROOTH and mortality.

Females

Parameter HR [95% CI] p-value
G6_NEUROOTH 1.537 [1.37, 1.72] < 0.001
Birth year 0.994 [0.98, 1.0] 0.136

During the follow-up period (1.1.1998 — 31.12.2019), 1028 out of 5356 females with G6_NEUROOTH died.

Males

Parameter HR [95% CI] p-value
G6_NEUROOTH 1.566 [1.4, 1.75] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1427 out of 6181 males with G6_NEUROOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_NEUROOTH.

N-year risk Females Males
1 0.143% 0.305%
5 0.884% 1.664%
10 2.071% 4.471%
15 4.006% 8.346%
20 6.955% 13.924%

Relationships between endpoints

Index endpoint: G6_NEUROOTH – Other disorders of nervous system

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data